Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
MAC.MDM.complement_resolving: Meta traits — page 5
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 1,931 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 4,001–5,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 4001 | Hearing loss | AUDIO000013 | 0.28 | Auditory | Neural / glial | 54 | 1 | 3 | 11 | |
| 4002 | MEP1A levels | PROLV001297 | 0.28 | Protein levels | Hepatocyte | 100 | 1 | 7 | 11 | |
| 4003 | Autoimmune disease | IMMUN000023 | 0.28 | Immunologic | Lymphocyte | 287 | 2 | 12 | 15 | |
| 4004 | GP5 levels | PROLV000916 | 0.28 | Protein levels | Lymphocyte | 1 | 4 | 10 | 27 | |
| 4005 | CD79B/TNFRSF13B ratio | PRORT000513 | 0.28 | Protein ratios | B / plasma cell | 14 | 2 | 5 | 6 | |
| 4006 | NUMB levels | PROLV001456 | 0.28 | Protein levels | Stromal / connective | 16 | 3 | 9 | 17 | |
| 4007 | PDCD1/TNFRSF4 ratio | PRORT001629 | 0.28 | Protein ratios | Lymphocyte | 11 | 1 | 16 | 18 | |
| 4008 | Blood pressure, BP, systolic | VASCU000011 | 0.28 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 4009 | SAP18 levels | PROLV001775 | 0.28 | Protein levels | Hepatocyte | 3 | 3 | 7 | 13 | |
| 4010 | LDLRAP1 levels | PROLV001195 | 0.28 | Protein levels | Stromal / connective | 2 | 4 | 6 | 13 | |
| 4011 | PPY levels | PROLV001622 | 0.27 | Protein levels | Vascular | 12 | 0 | 2 | 9 | |
| 4012 | CSF2 levels | PROLV000538 | 0.27 | Protein levels | Muscle / cardiac | 12 | 1 | 2 | 21 | |
| 4013 | MESD/SNX9 ratio | PRORT001517 | 0.27 | Protein ratios | Stromal / connective | 1 | 5 | 10 | 28 | |
| 4014 | LPL levels | PROLV001222 | 0.27 | Protein levels | Hepatocyte | 51 | 2 | 6 | 10 | |
| 4015 | DARS1/EIF4B ratio | PRORT000858 | 0.27 | Protein ratios | Hepatocyte | 0 | 3 | 8 | 30 | |
| 4016 | Bacterial intestinal infection | IMMUN000052 | 0.27 | Immunologic | Neural / glial | 0 | 1 | 2 | 9 | |
| 4017 | Household composition | SOCIO000010 | 0.27 | Socioeconomic | Neural / glial | 0 | 4 | 14 | 29 | |
| 4018 | IFIT3 levels | PROLV001017 | 0.27 | Protein levels | Stromal / connective | 0 | 2 | 5 | 12 | |
| 4019 | Waist circumference | BMORP000013 | 0.27 | Body morphology | Neural / glial | 286 | 5 | 8 | 19 | |
| 4020 | RABEP1 levels | PROLV001701 | 0.27 | Protein levels | Vascular | 10 | 4 | 10 | 41 | |
| 4021 | OLFM4 levels | PROLV001466 | 0.27 | Protein levels | Myeloid | 42 | 2 | 8 | 17 | |
| 4022 | Coronary artery calcification | VASCU000055 | 0.27 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 4023 | PCDH1 levels | PROLV001504 | 0.27 | Protein levels | Hepatocyte | 21 | 3 | 8 | 14 | |
| 4024 | Viral intestinal infection | IMMUN000077 | 0.27 | Immunologic | Hepatocyte | 3 | 1 | 5 | 11 | |
| 4025 | BMP6/SPINT2 ratio | PRORT000244 | 0.27 | Protein ratios | Lymphocyte | 10 | 2 | 8 | 27 | |
| 4026 | NUB1 levels | PROLV001449 | 0.27 | Protein levels | Stromal / connective | 1 | 3 | 7 | 13 | |
| 4027 | DSC2/SPINT1 ratio | PRORT000951 | 0.27 | Protein ratios | Epithelial | 23 | 0 | 7 | 3 | |
| 4028 | CRH levels | PROLV000520 | 0.26 | Protein levels | Hematopoietic progenitor | 35 | 1 | 1 | 7 | |
| 4029 | ALPP/LAMP3 ratio | PRORT000082 | 0.26 | Protein ratios | Gastrointestinal epithelium | 12 | 0 | 6 | 12 | |
| 4030 | NBN levels | PROLV001376 | 0.26 | Protein levels | Lymphocyte | 10 | 2 | 14 | 38 | |
| 4031 | Implant | MISCL000025 | 0.26 | Miscellaneous | Stromal / connective | 0 | 0 | 0 | 0 | |
| 4032 | Free androgen index | ENDOC000007 | 0.26 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 4033 | RBM17 levels | PROLV001710 | 0.26 | Protein levels | Vascular | 9 | 0 | 3 | 10 | |
| 4034 | Cancer, Oesophagus | MALIG000021 | 0.26 | Malignancy | Salivary epithelium | 1 | 0 | 2 | 4 | |
| 4035 | ACE2/MME ratio | PRORT000012 | 0.26 | Protein ratios | Hepatocyte | 40 | 1 | 5 | 9 | |
| 4036 | INPP1 levels | PROLV001089 | 0.26 | Protein levels | Stromal / connective | 0 | 2 | 6 | 19 | |
| 4037 | KL levels | PROLV001147 | 0.26 | Protein levels | Neural / glial | 1 | 1 | 3 | 12 | |
| 4038 | ANGPT1/APP ratio | PRORT000091 | 0.26 | Protein ratios | Hematopoietic progenitor | 5 | 3 | 3 | 7 | |
| 4039 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 0.26 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 4040 | PAXX levels | PROLV001499 | 0.26 | Protein levels | Lymphocyte | 14 | 4 | 15 | 31 | |
| 4041 | Sun exposure | BEHAV000001 | 0.26 | Behavioural | Neural / glial | 80 | 3 | 7 | 21 | |
| 4042 | Chronic bronchitis | RESPI000010 | 0.26 | Respiratory | Neural / glial | 1 | 1 | 2 | 7 | |
| 4043 | SUSD4 levels | PROLV001980 | 0.26 | Protein levels | Hepatocyte | 26 | 1 | 3 | 11 | |
| 4044 | Pain, joint | MSKEL000036 | 0.26 | Musculoskeletal | Neural / glial | 6 | 2 | 6 | 24 | |
| 4045 | ATG4A/NSFL1C ratio | PRORT000149 | 0.26 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 5 | 9 | |
| 4046 | Haemorrhoidal disease | VASCU000062 | 0.26 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 4047 | ACP6 levels | PROLV000015 | 0.25 | Protein levels | Myeloid | 27 | 2 | 8 | 9 | |
| 4048 | ICAM4 levels | PROLV001007 | 0.25 | Protein levels | Lymphocyte | 53 | 2 | 13 | 33 | |
| 4049 | Oesophageal disorder | GASTR000050 | 0.25 | Gastrointestinal | Neural / glial | 15 | 2 | 10 | 21 | |
| 4050 | MESD levels | PROLV001301 | 0.25 | Protein levels | Platelet | 9 | 6 | 7 | 11 | |
| 4051 | FUT8/TNFSF12 ratio | PRORT001191 | 0.25 | Protein ratios | Platelet | 11 | 4 | 15 | 30 | |
| 4052 | PLIN3/VSIR ratio | PRORT001683 | 0.25 | Protein ratios | Vascular | 4 | 2 | 3 | 14 | |
| 4053 | ST8SIA1 levels | PROLV001955 | 0.25 | Protein levels | Renal epithelium | 6 | 0 | 4 | 4 | |
| 4054 | Haemoglobin status | HEMAT000009 | 0.25 | Hematologic | Stromal / connective | 1 | 1 | 2 | 6 | |
| 4055 | CXADR/GGT1 ratio | PRORT000812 | 0.25 | Protein ratios | Hepatocyte | 17 | 1 | 4 | 10 | |
| 4056 | IL6R levels | PROLV001078 | 0.25 | Protein levels | Myeloid | 41 | 1 | 4 | 9 | |
| 4057 | DTNB levels | PROLV000659 | 0.25 | Protein levels | Muscle / cardiac | 0 | 2 | 6 | 24 | |
| 4058 | Hip index | BMORP000012 | 0.25 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 4059 | CEACAM1 levels | PROLV000387 | 0.25 | Protein levels | Hepatocyte | 47 | 1 | 6 | 11 | |
| 4060 | TGFBR2/THBD ratio | PRORT001833 | 0.25 | Protein ratios | Vascular | 24 | 1 | 5 | 23 | |
| 4061 | Haemoglobin | HEMAT000007 | 0.25 | Hematologic | Hepatocyte | 2,197 | 1 | 4 | 10 | |
| 4062 | Trihexosylceramides | LIPID000073 | 0.25 | Lipids | Granulosa cell | 7 | 2 | 5 | 4 | |
| 4063 | CETN2 levels | PROLV000408 | 0.25 | Protein levels | Platelet | 1 | 2 | 9 | 19 | |
| 4064 | Pain, multi-site | MSKEL000038 | 0.24 | Musculoskeletal | Neural / glial | 13 | 5 | 10 | 28 | |
| 4065 | CD58/MCAM ratio | PRORT000476 | 0.24 | Protein ratios | Adipose | 2 | 1 | 6 | 12 | |
| 4066 | Liver fat | HPBIL000023 | 0.24 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 4067 | FAM151A levels | PROLV000760 | 0.24 | Protein levels | Neural / glial | 0 | 5 | 9 | 15 | |
| 4068 | MGLL/PDLIM7 ratio | PRORT001528 | 0.24 | Protein ratios | Hepatocyte | 10 | 2 | 8 | 13 | |
| 4069 | CXCL3/MGLL ratio | PRORT000826 | 0.24 | Protein ratios | Platelet | 0 | 2 | 5 | 16 | |
| 4070 | HYOU1/ROR1 ratio | PRORT001316 | 0.24 | Protein ratios | Hepatocyte | 41 | 1 | 6 | 6 | |
| 4071 | SCN4B levels | PROLV001791 | 0.24 | Protein levels | Myeloid | 54 | 1 | 6 | 12 | |
| 4072 | PRDX5 levels | PROLV001626 | 0.24 | Protein levels | Stromal / connective | 15 | 4 | 10 | 16 | |
| 4073 | GP2/SELE ratio | PRORT001231 | 0.24 | Protein ratios | Pancreatic epithelium | 13 | 0 | 4 | 10 | |
| 4074 | CBLN4 levels | PROLV000272 | 0.24 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 4075 | SFTPA2/SFTPD ratio | PRORT001782 | 0.24 | Protein ratios | Epithelial | 11 | 1 | 4 | 4 | |
| 4076 | TSHB levels | PROLV002114 | 0.24 | Protein levels | Renal epithelium | 34 | 0 | 8 | 4 | |
| 4077 | Pain, neck | MSKEL000040 | 0.24 | Musculoskeletal | Neural / glial | 3 | 3 | 16 | 34 | |
| 4078 | Reimbursement for rheumatic disease | IMMUN000042 | 0.24 | Immunologic | Lymphocyte | 112 | 2 | 16 | 16 | |
| 4079 | PDGFC/TFPI ratio | PRORT001653 | 0.24 | Protein ratios | Hepatocyte | 52 | 2 | 12 | 21 | |
| 4080 | PYY levels | PROLV001690 | 0.24 | Protein levels | Neural / glial | 56 | 2 | 8 | 11 | |
| 4081 | CDA levels | PROLV000365 | 0.24 | Protein levels | Lymphocyte | 42 | 2 | 13 | 28 | |
| 4082 | ITGB1BP2/TIA1 ratio | PRORT001389 | 0.24 | Protein ratios | Lymphocyte | 21 | 4 | 12 | 27 | |
| 4083 | Retinal vascular disorder | OPHTH000044 | 0.24 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 4084 | ERP44 levels | PROLV000732 | 0.23 | Protein levels | Hepatocyte | 67 | 6 | 14 | 38 | |
| 4085 | MAP2K6/NT5C3A ratio | PRORT001486 | 0.23 | Protein ratios | Muscle / cardiac | 12 | 6 | 8 | 16 | |
| 4086 | MLN/TNFRSF12A ratio | PRORT001539 | 0.23 | Protein ratios | Neural / glial | 18 | 1 | 3 | 4 | |
| 4087 | Childhood maltreatment | PSYCH000052 | 0.23 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 4088 | BCL2L11/RAB6A ratio | PRORT000220 | 0.23 | Protein ratios | Hepatocyte | 26 | 1 | 6 | 8 | |
| 4089 | Mood disorder | PSYCH000028 | 0.23 | Psychiatric | Neural / glial | 8 | 5 | 10 | 11 | |
| 4090 | Creatinine | NEPHR000018 | 0.23 | Nephrourologic | Hepatocyte | 2,903 | 2 | 6 | 8 | |
| 4091 | VPS4B levels | PROLV002167 | 0.23 | Protein levels | Stromal / connective | 9 | 4 | 8 | 15 | |
| 4092 | Frailty, limited social support | SOCIO000017 | 0.23 | Socioeconomic | Neural / glial | 0 | 4 | 4 | 9 | |
| 4093 | CD84 levels | PROLV000359 | 0.23 | Protein levels | Neural / glial | 16 | 3 | 10 | 8 | |
| 4094 | TGFBR3 levels | PROLV002023 | 0.23 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 4095 | REG4 levels | PROLV001720 | 0.23 | Protein levels | Pancreatic epithelium | 61 | 0 | 6 | 9 | |
| 4096 | PVALB levels | PROLV001686 | 0.23 | Protein levels | Hematopoietic progenitor | 16 | 3 | 3 | 9 | |
| 4097 | IL31RA levels | PROLV001071 | 0.23 | Protein levels | Granulosa cell | 1 | 3 | 7 | 13 | |
| 4098 | Transport mode | BEHAV000009 | 0.23 | Behavioural | Neural / glial | 17 | 4 | 7 | 10 | |
| 4099 | Medical device use, CPAP | RESPI000024 | 0.23 | Respiratory | Hepatocyte | 0 | 3 | 6 | 19 | |
| 4100 | LAYN/ULBP2 ratio | PRORT001435 | 0.23 | Protein ratios | Neural / glial | 3 | 1 | 8 | 13 | |
| 4101 | Bleeding | HEMAT000016 | 0.22 | Hematologic | B / plasma cell | 9 | 1 | 4 | 17 | |
| 4102 | Pyloric stenosis | GASTR000052 | 0.22 | Gastrointestinal | B / plasma cell | 0 | 0 | 6 | 6 | |
| 4103 | Cannabis use | PSYCH000045 | 0.22 | Psychiatric | Neural / glial | 9 | 5 | 11 | 26 | |
| 4104 | Hospital stay | MISCL000024 | 0.22 | Miscellaneous | Neural / glial | 2 | 1 | 3 | 6 | |
| 4105 | Medication, dermatologic | DERMA000024 | 0.22 | Dermatologic | Lymphocyte | 18 | 2 | 18 | 21 | |
| 4106 | TNFRSF19 levels | PROLV002067 | 0.22 | Protein levels | Muscle / cardiac | 8 | 1 | 8 | 14 | |
| 4107 | LAT2/YES1 ratio | PRORT001432 | 0.22 | Protein ratios | Hematopoietic progenitor | 10 | 2 | 6 | 7 | |
| 4108 | ARHGAP25 levels | PROLV000136 | 0.22 | Protein levels | Hepatocyte | 6 | 0 | 2 | 7 | |
| 4109 | CCNE1 levels | PROLV000306 | 0.22 | Protein levels | B / plasma cell | 8 | 0 | 6 | 17 | |
| 4110 | ENO2 levels | PROLV000706 | 0.22 | Protein levels | Lymphocyte | 3 | 2 | 5 | 17 | |
| 4111 | Passive smoking | MISCL000007 | 0.22 | Miscellaneous | Neural / glial | 0 | 3 | 8 | 18 | |
| 4112 | CCDC80/CHRDL1 ratio | PRORT000333 | 0.22 | Protein ratios | Vascular | 10 | 1 | 5 | 15 | |
| 4113 | SERPINC1 levels | PROLV001828 | 0.22 | Protein levels | Hepatocyte | 51 | 1 | 7 | 16 | |
| 4114 | CD79B/TNFRSF4 ratio | PRORT000514 | 0.22 | Protein ratios | B / plasma cell | 45 | 3 | 16 | 20 | |
| 4115 | NT5C3A levels | PROLV001440 | 0.22 | Protein levels | Stromal / connective | 13 | 6 | 11 | 20 | |
| 4116 | FUT8/VEGFC ratio | PRORT001193 | 0.22 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 4117 | HGF/PDGFB ratio | PRORT001284 | 0.22 | Protein ratios | Hepatocyte | 11 | 2 | 6 | 17 | |
| 4118 | Ventricular mass-to-volume ratio | CARDI000013 | 0.21 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 4119 | ESAM levels | PROLV000733 | 0.21 | Protein levels | Muscle / cardiac | 25 | 3 | 8 | 11 | |
| 4120 | PCBP2 levels | PROLV001503 | 0.21 | Protein levels | Lymphocyte | 33 | 4 | 11 | 19 | |
| 4121 | Corneal keratometry | OPHTH000006 | 0.21 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 4122 | MEPE levels | PROLV001299 | 0.21 | Protein levels | Muscle / cardiac | 39 | 2 | 7 | 17 | |
| 4123 | ZFYVE19 levels | PROLV002211 | 0.21 | Protein levels | Lymphocyte | 4 | 3 | 7 | 22 | |
| 4124 | Height decline | BMORP000010 | 0.21 | Body morphology | Hepatocyte | 1 | 2 | 6 | 13 | |
| 4125 | CAMK1D levels | PROLV000259 | 0.21 | Protein levels | Hepatocyte | 9 | 2 | 8 | 12 | |
| 4126 | PDGFB/VEGFC ratio | PRORT001652 | 0.21 | Protein ratios | Neural / glial | 27 | 6 | 12 | 33 | |
| 4127 | Non-cancer illness burden | MISCL000029 | 0.21 | Miscellaneous | Neural / glial | 24 | 5 | 8 | 15 | |
| 4128 | Dyspnoea | RESPI000028 | 0.21 | Respiratory | Neural / glial | 21 | 5 | 12 | 41 | |
| 4129 | LHPP levels | PROLV001209 | 0.21 | Protein levels | Lymphocyte | 19 | 2 | 14 | 44 | |
| 4130 | CSNK1D levels | PROLV000542 | 0.21 | Protein levels | Lymphocyte | 32 | 2 | 12 | 32 | |
| 4131 | ANXA11 levels | PROLV000106 | 0.21 | Protein levels | Stromal / connective | 26 | 2 | 5 | 15 | |
| 4132 | Vestibular disorder | AUDIO000022 | 0.21 | Auditory | Neural / glial | 0 | 2 | 4 | 13 | |
| 4133 | Blood pressure, BP, arterial | VASCU000007 | 0.21 | Vascular | Vascular | 603 | 3 | 7 | 9 | |
| 4134 | Glaucoma | OPHTH000009 | 0.21 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 4135 | CD79B/ICAM3 ratio | PRORT000512 | 0.21 | Protein ratios | B / plasma cell | 22 | 2 | 8 | 6 | |
| 4136 | CD8A levels | PROLV000361 | 0.21 | Protein levels | Lymphocyte | 149 | 2 | 10 | 16 | |
| 4137 | Arterial dissection | VASCU000003 | 0.21 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 4138 | NEO1 levels | PROLV001392 | 0.21 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 4139 | PRUNE2 levels | PROLV001652 | 0.21 | Protein levels | Hepatocyte | 23 | 1 | 3 | 15 | |
| 4140 | YOD1 levels | PROLV002206 | 0.20 | Protein levels | Lymphocyte | 0 | 4 | 12 | 40 | |
| 4141 | AXIN1/CLIP2 ratio | PRORT000167 | 0.20 | Protein ratios | Granulosa cell | 10 | 1 | 5 | 8 | |
| 4142 | SERPINA12 levels | PROLV001816 | 0.20 | Protein levels | Hepatocyte | 63 | 3 | 11 | 18 | |
| 4143 | MLN levels | PROLV001319 | 0.20 | Protein levels | Hepatocyte | 83 | 1 | 4 | 9 | |
| 4144 | SMNDC1 levels | PROLV001898 | 0.20 | Protein levels | Neural / glial | 5 | 4 | 12 | 34 | |
| 4145 | CBLIF levels | PROLV000271 | 0.20 | Protein levels | Vascular | 80 | 1 | 6 | 7 | |
| 4146 | CA5A/KRT18 ratio | PRORT000288 | 0.20 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 4147 | Urinary system disorder | NEPHR000005 | 0.20 | Nephrourologic | Neural / glial | 1 | 2 | 7 | 9 | |
| 4148 | FABP9 levels | PROLV000757 | 0.20 | Protein levels | Cutaneous epithelium | 43 | 0 | 4 | 5 | |
| 4149 | ROR1 levels | PROLV001751 | 0.20 | Protein levels | Hepatocyte | 77 | 1 | 4 | 10 | |
| 4150 | METAP2 levels | PROLV001304 | 0.20 | Protein levels | Stromal / connective | 8 | 5 | 13 | 36 | |
| 4151 | CDC42BPB levels | PROLV000369 | 0.20 | Protein levels | Vascular | 6 | 1 | 4 | 9 | |
| 4152 | Spinal deformity | MSKEL000077 | 0.20 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 4153 | MCEMP1 levels | PROLV001285 | 0.20 | Protein levels | Myeloid | 46 | 3 | 8 | 17 | |
| 4154 | Corneal disorder | OPHTH000003 | 0.20 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 4155 | MANF levels | PROLV001262 | 0.20 | Protein levels | Myeloid | 26 | 4 | 7 | 20 | |
| 4156 | PTPRH levels | PROLV001676 | 0.20 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 4157 | TPI1 levels | PROLV002093 | 0.20 | Protein levels | Neural / glial | 1 | 1 | 13 | 20 | |
| 4158 | HJV levels | PROLV000971 | 0.20 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 4159 | FCRL6 levels | PROLV000787 | 0.20 | Protein levels | Lymphocyte | 109 | 2 | 11 | 30 | |
| 4160 | TNFRSF9 levels | PROLV002074 | 0.20 | Protein levels | B / plasma cell | 81 | 1 | 15 | 24 | |
| 4161 | KRT5 levels | PROLV001167 | 0.20 | Protein levels | Cutaneous epithelium | 11 | 0 | 11 | 17 | |
| 4162 | Hypokalaemia | METBL000006 | 0.20 | Metabolic | Hepatocyte | 0 | 1 | 4 | 15 | |
| 4163 | METAP2/PFKFB2 ratio | PRORT001523 | 0.20 | Protein ratios | Muscle / cardiac | 1 | 3 | 9 | 18 | |
| 4164 | AHCY/FABP5 ratio | PRORT000054 | 0.20 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 14 | |
| 4165 | SEL1L levels | PROLV001802 | 0.20 | Protein levels | Myeloid | 0 | 1 | 3 | 5 | |
| 4166 | BID levels | PROLV000195 | 0.20 | Protein levels | Myeloid | 15 | 3 | 7 | 16 | |
| 4167 | Headache | NEURO000009 | 0.20 | Neurologic | Neural / glial | 18 | 1 | 5 | 18 | |
| 4168 | YES1 levels | PROLV002205 | 0.20 | Protein levels | Hepatocyte | 28 | 2 | 6 | 13 | |
| 4169 | HEXIM1/IPCEF1 ratio | PRORT001277 | 0.19 | Protein ratios | Neural / glial | 2 | 1 | 5 | 16 | |
| 4170 | CD244/FCRL6 ratio | PRORT000408 | 0.19 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 4171 | Iron deficiency anaemia | HEMAT000011 | 0.19 | Hematologic | Hepatocyte | 16 | 1 | 3 | 9 | |
| 4172 | WFDC12 levels | PROLV002189 | 0.19 | Protein levels | Cutaneous epithelium | 113 | 1 | 7 | 9 | |
| 4173 | PTRHD1 levels | PROLV001683 | 0.19 | Protein levels | Lymphocyte | 1 | 3 | 8 | 29 | |
| 4174 | Contact dermatitis | DERMA000007 | 0.19 | Dermatologic | Lymphocyte | 10 | 2 | 14 | 16 | |
| 4175 | BLVRB/CA2 ratio | PRORT000239 | 0.19 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 4176 | PTPRR levels | PROLV001680 | 0.19 | Protein levels | Epithelial | 0 | 0 | 7 | 15 | |
| 4177 | LTA/LTBR ratio | PRORT001463 | 0.19 | Protein ratios | B / plasma cell | 14 | 1 | 7 | 32 | |
| 4178 | CRTAM levels | PROLV000530 | 0.19 | Protein levels | Lymphocyte | 122 | 2 | 13 | 20 | |
| 4179 | IRAK4 levels | PROLV001098 | 0.19 | Protein levels | Stromal / connective | 19 | 4 | 8 | 17 | |
| 4180 | Cerebral ischaemia | VASCU000012 | 0.19 | Vascular | Neural / glial | 1 | 2 | 7 | 5 | |
| 4181 | CERT/PRTFDC1 ratio | PRORT000606 | 0.19 | Protein ratios | Hepatocyte | 0 | 2 | 6 | 13 | |
| 4182 | F8 levels | PROLV000749 | 0.19 | Protein levels | Neural / glial | 2 | 2 | 6 | 11 | |
| 4183 | Orofacial cleft | DENTA000001 | 0.19 | Dental | Neural / glial | 0 | 1 | 10 | 17 | |
| 4184 | SLC5A8 levels | PROLV001884 | 0.19 | Protein levels | Hepatocyte | 11 | 3 | 7 | 10 | |
| 4185 | CD40LG/EGF ratio | PRORT000449 | 0.19 | Protein ratios | Hepatocyte | 1 | 2 | 8 | 34 | |
| 4186 | MAMDC4 levels | PROLV001259 | 0.19 | Protein levels | Hepatocyte | 46 | 2 | 7 | 11 | |
| 4187 | CSNK2A1 or CSNK2B levels | PROLV000545 | 0.19 | Protein levels | B / plasma cell | 1 | 0 | 8 | 5 | |
| 4188 | Obesity | METBL000008 | 0.19 | Metabolic | Neural / glial | 238 | 5 | 12 | 22 | |
| 4189 | CASP2 levels | PROLV000267 | 0.19 | Protein levels | Lymphocyte | 16 | 3 | 6 | 29 | |
| 4190 | CX3CL1 levels | PROLV000573 | 0.19 | Protein levels | Vascular | 67 | 2 | 4 | 14 | |
| 4191 | PSCA levels | PROLV001655 | 0.19 | Protein levels | Neural / glial | 5 | 1 | 4 | 12 | |
| 4192 | PIK3IP1/RGMB ratio | PRORT001665 | 0.19 | Protein ratios | Neural / glial | 0 | 0 | 8 | 11 | |
| 4193 | ADGRD1 levels | PROLV000041 | 0.19 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 4194 | Radiation effects | MISCL000008 | 0.19 | Miscellaneous | Muscle / cardiac | 0 | 1 | 6 | 12 | |
| 4195 | GAL/PM20D1 ratio | PRORT001200 | 0.19 | Protein ratios | Vascular | 23 | 3 | 14 | 18 | |
| 4196 | ERN1 levels | PROLV000730 | 0.18 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 4197 | GASK1A levels | PROLV000856 | 0.18 | Protein levels | Hepatocyte | 49 | 1 | 4 | 10 | |
| 4198 | Social activity | SOCIO000020 | 0.18 | Socioeconomic | Neural / glial | 22 | 4 | 10 | 18 | |
| 4199 | GHR levels | PROLV000885 | 0.18 | Protein levels | Hepatocyte | 17 | 2 | 7 | 23 | |
| 4200 | XG levels | PROLV002197 | 0.18 | Protein levels | Vascular | 20 | 1 | 4 | 13 | |
| 4201 | EFEMP1 levels | PROLV000679 | 0.18 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 4202 | CD84/GP6 ratio | PRORT000525 | 0.18 | Protein ratios | Hepatocyte | 7 | 5 | 13 | 19 | |
| 4203 | CDH6 levels | PROLV000377 | 0.18 | Protein levels | Hepatocyte | 17 | 3 | 12 | 29 | |
| 4204 | GRAP2/PLPBP ratio | PRORT001242 | 0.18 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 17 | |
| 4205 | EIF4G1/TBC1D23 ratio | PRORT001014 | 0.18 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 4206 | TACSTD2 levels | PROLV001989 | 0.18 | Protein levels | Neural / glial | 29 | 1 | 3 | 8 | |
| 4207 | PPP1R14D levels | PROLV001615 | 0.18 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 4208 | STIP1 levels | PROLV001962 | 0.18 | Protein levels | Lymphocyte | 3 | 2 | 12 | 38 | |
| 4209 | Family history, skin cancer | MALIG000040 | 0.18 | Malignancy | B / plasma cell | 8 | 0 | 3 | 9 | |
| 4210 | BACH1/HEXIM1 ratio | PRORT000195 | 0.18 | Protein ratios | Muscle / cardiac | 0 | 2 | 10 | 16 | |
| 4211 | LGALS7_LGALS7B/WFDC12 ratio | PRORT001452 | 0.18 | Protein ratios | Respiratory epithelium | 4 | 0 | 18 | 12 | |
| 4212 | BLOC1S3 levels | PROLV000201 | 0.18 | Protein levels | Myeloid | 19 | 2 | 2 | 6 | |
| 4213 | LAMA4/PDGFB ratio | PRORT001420 | 0.18 | Protein ratios | Neural / glial | 19 | 3 | 10 | 28 | |
| 4214 | APRT/MIF ratio | PRORT000135 | 0.18 | Protein ratios | Lymphocyte | 2 | 4 | 14 | 40 | |
| 4215 | PON2/PON3 ratio | PRORT001698 | 0.18 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 4216 | ALCAM/SPINT1 ratio | PRORT000076 | 0.18 | Protein ratios | Respiratory epithelium | 41 | 1 | 7 | 13 | |
| 4217 | NXPH3 levels | PROLV001458 | 0.18 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 4218 | PCDH7 levels | PROLV001507 | 0.18 | Protein levels | Neural / glial | 6 | 2 | 9 | 16 | |
| 4219 | Hearing loss, sensorineural | AUDIO000008 | 0.18 | Auditory | Neural / glial | 38 | 2 | 9 | 8 | |
| 4220 | GBP4 levels | PROLV000862 | 0.18 | Protein levels | Neural / glial | 4 | 3 | 11 | 25 | |
| 4221 | Alcohol consumption | PSYCH000041 | 0.18 | Psychiatric | Neural / glial | 63 | 4 | 9 | 18 | |
| 4222 | CACNB3 levels | PROLV000251 | 0.18 | Protein levels | Vascular | 2 | 1 | 3 | 18 | |
| 4223 | Cardiometabolic multimorbidity | METBL000013 | 0.17 | Metabolic | Hepatocyte | 17 | 2 | 7 | 9 | |
| 4224 | Falling risk | MISCL000040 | 0.17 | Miscellaneous | Neural / glial | 1 | 3 | 5 | 5 | |
| 4225 | MEGF9/OXT ratio | PRORT001514 | 0.17 | Protein ratios | Hepatocyte | 34 | 1 | 4 | 15 | |
| 4226 | CST5 levels | PROLV000550 | 0.17 | Protein levels | Gastrointestinal epithelium | 57 | 1 | 4 | 8 | |
| 4227 | Optic disc area | OPHTH000029 | 0.17 | Ophthalmic | Vascular | 11 | 4 | 7 | 13 | |
| 4228 | NSFL1C/UBAC1 ratio | PRORT001601 | 0.17 | Protein ratios | Muscle / cardiac | 21 | 2 | 5 | 13 | |
| 4229 | AXIN1/MAP2K6 ratio | PRORT000174 | 0.17 | Protein ratios | Granulosa cell | 0 | 3 | 5 | 12 | |
| 4230 | PLXNA4/SRPK2 ratio | PRORT001686 | 0.17 | Protein ratios | Muscle / cardiac | 7 | 3 | 10 | 37 | |
| 4231 | CCL22/PDGFB ratio | PRORT000351 | 0.17 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 4232 | Autoimmune hepatitis | IMMUN000024 | 0.17 | Immunologic | Neural / glial | — | 3 | 16 | 30 | |
| 4233 | BIRC2 levels | PROLV000198 | 0.17 | Protein levels | Stromal / connective | 1 | 3 | 7 | 14 | |
| 4234 | ANG/F9 ratio | PRORT000089 | 0.17 | Protein ratios | Hepatocyte | 31 | 1 | 6 | 6 | |
| 4235 | GFER levels | PROLV000875 | 0.17 | Protein levels | Muscle / cardiac | 1 | 4 | 11 | 27 | |
| 4236 | F7/VASN ratio | PRORT001089 | 0.17 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 12 | |
| 4237 | ZP3 levels | PROLV002215 | 0.17 | Protein levels | B / plasma cell | 28 | 1 | 6 | 17 | |
| 4238 | PODXL2/SDC1 ratio | PRORT001696 | 0.17 | Protein ratios | Hepatocyte | 33 | 2 | 8 | 13 | |
| 4239 | CDON/SCARA5 ratio | PRORT000581 | 0.17 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 4240 | GRPEL1 levels | PROLV000935 | 0.17 | Protein levels | Hepatocyte | 23 | 2 | 8 | 24 | |
| 4241 | LPCAT2 levels | PROLV001221 | 0.17 | Protein levels | Hepatocyte | 0 | 1 | 4 | 18 | |
| 4242 | ANP32B levels | PROLV000102 | 0.17 | Protein levels | Hepatocyte | 2 | 1 | 7 | 18 | |
| 4243 | CRYZL1 levels | PROLV000535 | 0.17 | Protein levels | Myeloid | 7 | 4 | 8 | 16 | |
| 4244 | Respiratory infection | IMMUN000070 | 0.17 | Immunologic | Lymphocyte | 29 | 2 | 14 | 22 | |
| 4245 | GIPC3 levels | PROLV000889 | 0.16 | Protein levels | Platelet | 7 | 3 | 4 | 7 | |
| 4246 | AHSA1 levels | PROLV000064 | 0.16 | Protein levels | Vascular | 1 | 0 | 2 | 16 | |
| 4247 | ICAM1/SELE ratio | PRORT001323 | 0.16 | Protein ratios | Granulosa cell | 2 | 1 | 9 | 17 | |
| 4248 | AGRN/HSPG2 ratio | PRORT000048 | 0.16 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 4249 | MNX1 levels | PROLV001330 | 0.16 | Protein levels | Neural / glial | 0 | 2 | 6 | 13 | |
| 4250 | KLK11/KLK8 ratio | PRORT001408 | 0.16 | Protein ratios | Cutaneous epithelium | 10 | 0 | 7 | 12 | |
| 4251 | ABHD14B/SPARC ratio | PRORT000007 | 0.16 | Protein ratios | Myeloid | 1 | 3 | 8 | 20 | |
| 4252 | SMPD1/SMPDL3A ratio | PRORT001792 | 0.16 | Protein ratios | Hepatocyte | 4 | 2 | 12 | 14 | |
| 4253 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 0.16 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 4254 | AARSD1/PIK3AP1 ratio | PRORT000001 | 0.16 | Protein ratios | Hematopoietic progenitor | 2 | 1 | 2 | 3 | |
| 4255 | Dietary change, none | DTSUP000005 | 0.16 | Diet and Supplement | Neural / glial | 19 | 3 | 12 | 8 | |
| 4256 | MEP1B levels | PROLV001298 | 0.16 | Protein levels | Hepatocyte | 85 | 1 | 4 | 4 | |
| 4257 | ADAM22 levels | PROLV000027 | 0.16 | Protein levels | Adipose | 54 | 0 | 6 | 8 | |
| 4258 | DOK2/PDLIM7 ratio | PRORT000940 | 0.16 | Protein ratios | Muscle / cardiac | 6 | 4 | 14 | 19 | |
| 4259 | METAP2/PLPBP ratio | PRORT001524 | 0.16 | Protein ratios | Granulosa cell | 7 | 2 | 9 | 9 | |
| 4260 | MET/PTPRF ratio | PRORT001520 | 0.16 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 9 | |
| 4261 | Carpal tunnel surgery | MSKEL000044 | 0.16 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 4262 | AMOTL2 levels | PROLV000088 | 0.16 | Protein levels | Lymphocyte | 1 | 0 | 9 | 14 | |
| 4263 | CRKL/MGLL ratio | PRORT000765 | 0.16 | Protein ratios | Hepatocyte | 27 | 3 | 9 | 16 | |
| 4264 | GP2 levels | PROLV000915 | 0.16 | Protein levels | Pancreatic epithelium | 17 | 0 | 4 | 6 | |
| 4265 | C8B levels | PROLV000237 | 0.16 | Protein levels | Hepatocyte | 31 | 3 | 16 | 31 | |
| 4266 | INPP1/TBCC ratio | PRORT001360 | 0.16 | Protein ratios | Hepatocyte | 8 | 1 | 7 | 10 | |
| 4267 | TIMM8A levels | PROLV002037 | 0.16 | Protein levels | Vascular | 17 | 4 | 8 | 16 | |
| 4268 | DUSP29 levels | PROLV000662 | 0.15 | Protein levels | Muscle / cardiac | 2 | 2 | 5 | 8 | |
| 4269 | Osteoarthritis, OA | MSKEL000012 | 0.15 | Musculoskeletal | Stromal / connective | 85 | 1 | 2 | 6 | |
| 4270 | MPIG6B/SUSD1 ratio | PRORT001559 | 0.15 | Protein ratios | Neural / glial | 6 | 3 | 10 | 14 | |
| 4271 | CST3/IGFBP6 ratio | PRORT000783 | 0.15 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 4272 | A body shape index, ABSI | BMORP000001 | 0.15 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 4273 | Ankylosing spondylitis | IMMUN000022 | 0.15 | Immunologic | Lymphocyte | 83 | 4 | 8 | 19 | |
| 4274 | Glucose regulation disorder | METBL000038 | 0.15 | Metabolic | Lymphocyte | 36 | 2 | 5 | 17 | |
| 4275 | CCN2/SPINT2 ratio | PRORT000368 | 0.15 | Protein ratios | Hepatocyte | 35 | 2 | 6 | 13 | |
| 4276 | Ventricular sphericity | CARDI000014 | 0.15 | Cardiac | Muscle / cardiac | 0 | 3 | 8 | 21 | |
| 4277 | WFDC1 levels | PROLV002188 | 0.15 | Protein levels | B / plasma cell | 2 | 2 | 3 | 5 | |
| 4278 | SCG2 levels | PROLV001784 | 0.15 | Protein levels | Hepatocyte | 20 | 1 | 7 | 11 | |
| 4279 | Medication, beta blocker | VASCU000034 | 0.15 | Vascular | Vascular | 48 | 3 | 8 | 16 | |
| 4280 | ACTA2 levels | PROLV000017 | 0.15 | Protein levels | Myeloid | 1 | 1 | 4 | 7 | |
| 4281 | NRGN levels | PROLV001433 | 0.15 | Protein levels | Stromal / connective | 2 | 4 | 10 | 27 | |
| 4282 | CXADR/MME ratio | PRORT000813 | 0.15 | Protein ratios | Epithelial | 21 | 1 | 3 | 6 | |
| 4283 | BCL2L15 levels | PROLV000188 | 0.15 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 4284 | CEP112 levels | PROLV000399 | 0.15 | Protein levels | Neural / glial | 0 | 2 | 5 | 11 | |
| 4285 | PEBP1 levels | PROLV001533 | 0.15 | Protein levels | Lymphocyte | 1 | 3 | 18 | 35 | |
| 4286 | Foot surgery | MSKEL000046 | 0.15 | Musculoskeletal | Hematopoietic progenitor | 2 | 2 | 6 | 12 | |
| 4287 | PCDH17/SEMA7A ratio | PRORT001626 | 0.15 | Protein ratios | Granulosa cell | 1 | 4 | 7 | 16 | |
| 4288 | TANK levels | PROLV001992 | 0.15 | Protein levels | Stromal / connective | 1 | 5 | 12 | 33 | |
| 4289 | TSC22D1 levels | PROLV002113 | 0.15 | Protein levels | Stromal / connective | 4 | 2 | 9 | 10 | |
| 4290 | TBC1D5 levels | PROLV001997 | 0.15 | Protein levels | Myeloid | 7 | 2 | 6 | 19 | |
| 4291 | GCG levels | PROLV000866 | 0.15 | Protein levels | Hepatocyte | 66 | 1 | 7 | 13 | |
| 4292 | Hearing difficulty | AUDIO000012 | 0.15 | Auditory | Neural / glial | 134 | 1 | 7 | 6 | |
| 4293 | CD58/SIRPB1 ratio | PRORT000479 | 0.15 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 2 | 5 | |
| 4294 | Vertigo | AUDIO000021 | 0.15 | Auditory | Neural / glial | 0 | 2 | 3 | 15 | |
| 4295 | BCR/ITGB1BP2 ratio | PRORT000227 | 0.15 | Protein ratios | Muscle / cardiac | 20 | 3 | 9 | 24 | |
| 4296 | AHSP/CA2 ratio | PRORT000057 | 0.15 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 5 | 17 | |
| 4297 | CRELD2/HYOU1 ratio | PRORT000756 | 0.15 | Protein ratios | Granulosa cell | 19 | 1 | 6 | 2 | |
| 4298 | Juvenile arthritis | IMMUN000032 | 0.15 | Immunologic | Salivary epithelium | 29 | 1 | 8 | 31 | |
| 4299 | Muscular dystrophy | MSKEL000028 | 0.15 | Musculoskeletal | Muscle / cardiac | 4 | 4 | 17 | 33 | |
| 4300 | YWHAQ levels | PROLV002208 | 0.14 | Protein levels | Vascular | 9 | 4 | 10 | 21 | |
| 4301 | Joint disorder | MSKEL000015 | 0.14 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 4302 | Lichen disorder | DERMA000013 | 0.14 | Dermatologic | Lymphocyte | 73 | 1 | 12 | 18 | |
| 4303 | Medication, antimigraine | NEURO000011 | 0.14 | Neurologic | Neural / glial | 0 | 2 | 7 | 8 | |
| 4304 | CORO1A levels | PROLV000499 | 0.14 | Protein levels | Platelet | 2 | 2 | 6 | 14 | |
| 4305 | CTSF levels | PROLV000564 | 0.14 | Protein levels | Hepatocyte | 134 | 1 | 6 | 11 | |
| 4306 | CD40LG/TNFSF14 ratio | PRORT000454 | 0.14 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 4307 | Professional qualification | SOCIO000003 | 0.14 | Socioeconomic | Neural / glial | 5 | 4 | 8 | 12 | |
| 4308 | IFNLR1 levels | PROLV001022 | 0.14 | Protein levels | Hepatocyte | 49 | 2 | 7 | 19 | |
| 4309 | AARSD1/UBAC1 ratio | PRORT000002 | 0.14 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 13 | |
| 4310 | SERPINB13 levels | PROLV001824 | 0.14 | Protein levels | Hepatocyte | 0 | 1 | 11 | 15 | |
| 4311 | Diabetes, type 1 with complication | IMMUN000011 | 0.14 | Immunologic | Neural / glial | 14 | 0 | 2 | 7 | |
| 4312 | RAB11FIP3 levels | PROLV001696 | 0.14 | Protein levels | Stromal / connective | 13 | 2 | 6 | 12 | |
| 4313 | Raynaud phenomenon | VASCU000060 | 0.14 | Vascular | Neural / glial | 2 | 0 | 5 | 12 | |
| 4314 | ENTPD2 levels | PROLV000712 | 0.14 | Protein levels | Hepatocyte | 48 | 1 | 4 | 10 | |
| 4315 | KLRK1 levels | PROLV001164 | 0.14 | Protein levels | Lymphocyte | 90 | 2 | 14 | 31 | |
| 4316 | Sjogren syndrome | IMMUN000043 | 0.14 | Immunologic | Lymphocyte | 33 | 2 | 11 | 18 | |
| 4317 | Alanine | METAB000017 | 0.14 | Metabolites | Hepatocyte | 251 | 1 | 5 | 12 | |
| 4318 | EGF/TNFSF14 ratio | PRORT000999 | 0.14 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 4319 | Female genital tract polyp | REPRO000009 | 0.14 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 4320 | Carotid intima-media thickness | VASCU000053 | 0.14 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 4321 | Cancer, Bladder | MALIG000009 | 0.14 | Malignancy | Cutaneous epithelium | 3 | 0 | 11 | 8 | |
| 4322 | Aneurysm | VASCU000001 | 0.14 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 4323 | RSPO1/SFRP1 ratio | PRORT001751 | 0.14 | Protein ratios | Hepatocyte | 0 | 1 | 5 | 8 | |
| 4324 | Pregnancy complication, ectopic | REPRO000028 | 0.14 | Reproductive | Vascular | 1 | 1 | 11 | 28 | |
| 4325 | PDCD1 levels | PROLV001515 | 0.14 | Protein levels | Lymphocyte | 69 | 2 | 13 | 19 | |
| 4326 | TAFA5 levels | PROLV001990 | 0.13 | Protein levels | Hepatocyte | 9 | 1 | 4 | 10 | |
| 4327 | CCL17/CCL22 ratio | PRORT000342 | 0.13 | Protein ratios | Muscle / cardiac | 3 | 4 | 10 | 31 | |
| 4328 | GRAP2 levels | PROLV000931 | 0.13 | Protein levels | Platelet | 6 | 7 | 9 | 18 | |
| 4329 | PTPRM/SELE ratio | PRORT001723 | 0.13 | Protein ratios | Granulosa cell | 2 | 1 | 6 | 14 | |
| 4330 | NCF2 levels | PROLV001380 | 0.13 | Protein levels | Muscle / cardiac | 2 | 2 | 7 | 14 | |
| 4331 | THBS2 levels | PROLV002026 | 0.13 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 4332 | FKBP14 levels | PROLV000807 | 0.13 | Protein levels | Myeloid | 20 | 3 | 6 | 16 | |
| 4333 | Arthropathy | MSKEL000013 | 0.13 | Musculoskeletal | Stromal / connective | 24 | 4 | 6 | 20 | |
| 4334 | Employment status | SOCIO000005 | 0.13 | Socioeconomic | Neural / glial | 0 | 3 | 5 | 21 | |
| 4335 | ARHGAP45 levels | PROLV000138 | 0.13 | Protein levels | Vascular | 15 | 2 | 4 | 24 | |
| 4336 | Pancreatitis | HPBIL000027 | 0.13 | Hepatopancreatobiliary | Hepatocyte | 57 | 0 | 1 | 7 | |
| 4337 | CDKN2D/ITGB1BP2 ratio | PRORT000578 | 0.13 | Protein ratios | Hematopoietic progenitor | 17 | 5 | 12 | 35 | |
| 4338 | Medical condition | MISCL000028 | 0.13 | Miscellaneous | Neural / glial | 16 | 3 | 10 | 16 | |
| 4339 | Fatty liver disease, nonalcoholic overweight | HPBIL000030 | 0.13 | Hepatopancreatobiliary | Neural / glial | 1 | 0 | 3 | 9 | |
| 4340 | Household income | SOCIO000026 | 0.13 | Socioeconomic | Neural / glial | 40 | 5 | 12 | 47 | |
| 4341 | SCGB3A1 levels | PROLV001787 | 0.13 | Protein levels | Respiratory epithelium | 31 | 0 | 5 | 12 | |
| 4342 | CD300LG levels | PROLV000333 | 0.13 | Protein levels | Vascular | 83 | 1 | 4 | 13 | |
| 4343 | Visual impairment | OPHTH000046 | 0.13 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 4344 | FOXO3 levels | PROLV000826 | 0.13 | Protein levels | Lymphocyte | 3 | 2 | 14 | 20 | |
| 4345 | Occupational physical activity | BEHAV000006 | 0.13 | Behavioural | Neural / glial | 28 | 4 | 8 | 20 | |
| 4346 | CDC37 levels | PROLV000368 | 0.13 | Protein levels | Platelet | 16 | 4 | 6 | 23 | |
| 4347 | Pelvic morphology | BMORP000021 | 0.13 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 4348 | S100A14 levels | PROLV001769 | 0.12 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 4349 | IRF3 levels | PROLV001100 | 0.12 | Protein levels | Neural / glial | 0 | 3 | 6 | 12 | |
| 4350 | MANF/PTPN6 ratio | PRORT001479 | 0.12 | Protein ratios | Muscle / cardiac | 9 | 1 | 5 | 13 | |
| 4351 | DRG2/SEMA4D ratio | PRORT000949 | 0.12 | Protein ratios | Hepatocyte | 6 | 3 | 17 | 35 | |
| 4352 | FAM3C/NECTIN2 ratio | PRORT001115 | 0.12 | Protein ratios | Vascular | 19 | 1 | 12 | 10 | |
| 4353 | Musculoskeletal soft tissue disorder | MSKEL000029 | 0.12 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 4354 | Fibroblastic disorder | MSKEL000064 | 0.12 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 4355 | Kidney failure | NEPHR000013 | 0.12 | Nephrourologic | Hepatocyte | 61 | 1 | 4 | 5 | |
| 4356 | GCHFR levels | PROLV000867 | 0.12 | Protein levels | Hepatocyte | 2 | 2 | 13 | 40 | |
| 4357 | CANT1/ROR1 ratio | PRORT000309 | 0.12 | Protein ratios | Hepatocyte | 3 | 1 | 9 | 25 | |
| 4358 | BOC levels | PROLV000207 | 0.12 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 4359 | Premature cardiac beat | CARDI000023 | 0.12 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 4360 | Reproductive timing | BEHAV000011 | 0.12 | Behavioural | Neural / glial | 48 | 5 | 9 | 16 | |
| 4361 | JPT2 levels | PROLV001127 | 0.12 | Protein levels | Lymphocyte | 2 | 4 | 10 | 20 | |
| 4362 | STAT2 levels | PROLV001958 | 0.12 | Protein levels | Vascular | 2 | 2 | 5 | 18 | |
| 4363 | BCHE levels | PROLV000184 | 0.12 | Protein levels | Hepatocyte | 114 | 1 | 5 | 11 | |
| 4364 | CLPS/CTRB1 ratio | PRORT000673 | 0.12 | Protein ratios | Pancreatic epithelium | 20 | 0 | 1 | 6 | |
| 4365 | CDH15 levels | PROLV000372 | 0.12 | Protein levels | Hepatocyte | 22 | 2 | 5 | 12 | |
| 4366 | Medication, heart failure | CARDI000044 | 0.12 | Cardiac | Hepatocyte | 0 | 3 | 6 | 20 | |
| 4367 | ENPP2/TNFRSF11B ratio | PRORT001034 | 0.12 | Protein ratios | Hepatocyte | 12 | 2 | 14 | 14 | |
| 4368 | Cerebrovascular disease | VASCU000013 | 0.12 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 4369 | SPRR3 levels | PROLV001939 | 0.12 | Protein levels | Gastrointestinal epithelium | 3 | 0 | 3 | 5 | |
| 4370 | DNAJC21 levels | PROLV000634 | 0.12 | Protein levels | Lymphocyte | 2 | 2 | 12 | 18 | |
| 4371 | Sacroiliitis | MSKEL000020 | 0.12 | Musculoskeletal | Muscle / cardiac | 35 | 4 | 9 | 31 | |
| 4372 | Sphingolipids | LIPID000071 | 0.11 | Lipids | Neural / glial | 0 | 1 | 4 | 7 | |
| 4373 | SERPINE1/SPARC ratio | PRORT001778 | 0.11 | Protein ratios | Muscle / cardiac | 1 | 2 | 6 | 13 | |
| 4374 | Anterior eye disorder | OPHTH000001 | 0.11 | Ophthalmic | Lymphocyte | 38 | 3 | 15 | 21 | |
| 4375 | JAM2/TNFRSF19 ratio | PRORT001400 | 0.11 | Protein ratios | Hematopoietic progenitor | 14 | 2 | 2 | 8 | |
| 4376 | HEPH levels | PROLV000963 | 0.11 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 4377 | Glutamate metabolites | METAB000005 | 0.11 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 4378 | AGXT levels | PROLV000060 | 0.11 | Protein levels | Hepatocyte | 122 | 1 | 6 | 9 | |
| 4379 | JAM2/TNFRSF14 ratio | PRORT001399 | 0.11 | Protein ratios | Platelet | 2 | 6 | 12 | 25 | |
| 4380 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 0.11 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 4381 | PSTPIP2 levels | PROLV001663 | 0.11 | Protein levels | Vascular | 10 | 4 | 9 | 14 | |
| 4382 | PDGFA/PRSS27 ratio | PRORT001633 | 0.11 | Protein ratios | Lymphocyte | 27 | 1 | 6 | 11 | |
| 4383 | FKBP1B/PRDX5 ratio | PRORT001151 | 0.11 | Protein ratios | Lymphocyte | 0 | 2 | 12 | 31 | |
| 4384 | Heme malignancy, Leukaemia | MALIG000042 | 0.11 | Malignancy | B / plasma cell | 7 | 1 | 4 | 14 | |
| 4385 | CD200/CNTNAP2 ratio | PRORT000393 | 0.11 | Protein ratios | Vascular | 18 | 1 | 4 | 10 | |
| 4386 | Retinal nerve fibre layer thickness | OPHTH000031 | 0.11 | Ophthalmic | Pancreatic epithelium | 8 | 0 | 3 | 8 | |
| 4387 | Iron content, Pancreas | METBL000017 | 0.11 | Metabolic | Muscle / cardiac | 0 | 0 | 2 | 11 | |
| 4388 | FCRL5/MZB1 ratio | PRORT001135 | 0.11 | Protein ratios | B / plasma cell | 4 | 2 | 3 | 3 | |
| 4389 | Operation, vascular | VASCU000058 | 0.11 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 4390 | Prurigo | DERMA000017 | 0.11 | Dermatologic | Lymphocyte | 1 | 2 | 8 | 29 | |
| 4391 | FUT3 levels | PROLV000837 | 0.11 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 4392 | DTD1 levels | PROLV000658 | 0.11 | Protein levels | Stromal / connective | 17 | 3 | 7 | 26 | |
| 4393 | Hearing aid use | AUDIO000011 | 0.11 | Auditory | Epithelial | 12 | 1 | 5 | 9 | |
| 4394 | DSG3 levels | PROLV000656 | 0.11 | Protein levels | Renal epithelium | 19 | 0 | 8 | 12 | |
| 4395 | SERPINB9 levels | PROLV001827 | 0.11 | Protein levels | Stromal / connective | 14 | 3 | 3 | 10 | |
| 4396 | TPD52L2 levels | PROLV002092 | 0.11 | Protein levels | Stromal / connective | 3 | 4 | 5 | 16 | |
| 4397 | Viral haemorrhagic fever | IMMUN000075 | 0.11 | Immunologic | Muscle / cardiac | 13 | 2 | 10 | 31 | |
| 4398 | Consultant specialty, dermatology | DERMA000005 | 0.11 | Dermatologic | B / plasma cell | 5 | 0 | 2 | 9 | |
| 4399 | SFRP4 levels | PROLV001846 | 0.11 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 4400 | IL7R levels | PROLV001081 | 0.11 | Protein levels | Hepatocyte | 78 | 3 | 10 | 27 | |
| 4401 | Hypertensive heart disease | CARDI000038 | 0.11 | Cardiac | Vascular | 23 | 0 | 1 | 8 | |
| 4402 | Administrative status | MISCL000021 | 0.11 | Miscellaneous | Neural / glial | 0 | 2 | 8 | 13 | |
| 4403 | FSHB levels | PROLV000828 | 0.10 | Protein levels | Myeloid | 0 | 1 | 7 | 14 | |
| 4404 | CNDP1/EGFR ratio | PRORT000677 | 0.10 | Protein ratios | Hepatocyte | 55 | 1 | 6 | 9 | |
| 4405 | DNM1 levels | PROLV000638 | 0.10 | Protein levels | Stromal / connective | 7 | 1 | 3 | 11 | |
| 4406 | MAP3K5 levels | PROLV001268 | 0.10 | Protein levels | Vascular | 0 | 1 | 4 | 12 | |
| 4407 | EHD3 levels | PROLV000690 | 0.10 | Protein levels | Stromal / connective | 14 | 5 | 8 | 17 | |
| 4408 | BMPER levels | PROLV000206 | 0.10 | Protein levels | Myeloid | 1 | 1 | 8 | 12 | |
| 4409 | EEF1D levels | PROLV000677 | 0.10 | Protein levels | Platelet | 14 | 4 | 5 | 16 | |
| 4410 | RBPMS2 levels | PROLV001714 | 0.10 | Protein levels | Vascular | 13 | 5 | 8 | 19 | |
| 4411 | NAP1L4 levels | PROLV001374 | 0.10 | Protein levels | Lymphocyte | 15 | 3 | 9 | 33 | |
| 4412 | TFF1/TFF2 ratio | PRORT001831 | 0.10 | Protein ratios | Pancreatic epithelium | 10 | 0 | 6 | 6 | |
| 4413 | Amino acid metabolism disorder | METBL000001 | 0.10 | Metabolic | Lymphocyte | 0 | 2 | 3 | 9 | |
| 4414 | Polycythaemia | HEMAT000012 | 0.10 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 4415 | IGFBP6/MFAP5 ratio | PRORT001336 | 0.10 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 4416 | NT5E levels | PROLV001441 | 0.10 | Protein levels | Hepatocyte | 96 | 1 | 10 | 9 | |
| 4417 | Arthropathy, ulcerative colitis | IMMUN000010 | 0.10 | Immunologic | Lymphocyte | 0 | 1 | 3 | 17 | |
| 4418 | Luteinizing hormone | ENDOC000008 | 0.10 | Endocrine | Muscle / cardiac | 0 | 5 | 7 | 15 | |
| 4419 | CD38 levels | PROLV000338 | 0.10 | Protein levels | Muscle / cardiac | 53 | 1 | 5 | 6 | |
| 4420 | EPCAM levels | PROLV000715 | 0.10 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 4421 | BCAM/EPO ratio | PRORT000208 | 0.10 | Protein ratios | Vascular | 30 | 2 | 8 | 10 | |
| 4422 | Body proportion | BMORP000019 | 0.10 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 4423 | Medication, ACE inhibitor | VASCU000028 | 0.10 | Vascular | Vascular | 12 | 0 | 2 | 3 | |
| 4424 | SHMT1 levels | PROLV001857 | 0.10 | Protein levels | Stromal / connective | 0 | 4 | 12 | 30 | |
| 4425 | ELOA levels | PROLV000701 | 0.10 | Protein levels | Neural / glial | 5 | 6 | 12 | 31 | |
| 4426 | COL6A3/HSPG2 ratio | PRORT000697 | 0.10 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 4427 | IGSF9 levels | PROLV001040 | 0.10 | Protein levels | Hepatocyte | 63 | 3 | 9 | 17 | |
| 4428 | KLK1 levels | PROLV001150 | 0.10 | Protein levels | Muscle / cardiac | 21 | 2 | 6 | 10 | |
| 4429 | DGKA levels | PROLV000616 | 0.10 | Protein levels | Lymphocyte | 0 | 1 | 10 | 32 | |
| 4430 | MZT1 levels | PROLV001367 | 0.10 | Protein levels | Vascular | 0 | 2 | 7 | 12 | |
| 4431 | Glutathione metabolites | METAB000006 | 0.10 | Metabolites | Neural / glial | 0 | 0 | 0 | 1 | |
| 4432 | Pulmonary heart disease | CARDI000027 | 0.10 | Cardiac | Hepatocyte | 56 | 3 | 8 | 16 | |
| 4433 | Hearing difficulty, none | AUDIO000005 | 0.10 | Auditory | Neural / glial | 33 | 2 | 8 | 10 | |
| 4434 | TMPRSS11D levels | PROLV002048 | 0.09 | Protein levels | Vascular | 3 | 2 | 5 | 12 | |
| 4435 | PSAPL1 levels | PROLV001654 | 0.09 | Protein levels | Cutaneous epithelium | 66 | 0 | 14 | 13 | |
| 4436 | Spinal stenosis | MSKEL000078 | 0.09 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 4437 | Uterine disorder | REPRO000043 | 0.09 | Reproductive | Vascular | 0 | 0 | 2 | 6 | |
| 4438 | ALDH1A1 levels | PROLV000079 | 0.09 | Protein levels | Hepatocyte | 16 | 2 | 9 | 22 | |
| 4439 | FST/FSTL3 ratio | PRORT001180 | 0.09 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 4440 | AREG levels | PROLV000132 | 0.09 | Protein levels | Vascular | 28 | 0 | 10 | 8 | |
| 4441 | PDGFB/TIMP3 ratio | PRORT001648 | 0.09 | Protein ratios | Hepatocyte | 15 | 1 | 8 | 25 | |
| 4442 | ARF6 levels | PROLV000133 | 0.09 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 4443 | NCK2/PLA2G4A ratio | PRORT001574 | 0.09 | Protein ratios | Granulosa cell | 1 | 4 | 15 | 24 | |
| 4444 | CFHR1 levels | PROLV000414 | 0.09 | Protein levels | Neural / glial | 6 | 2 | 6 | 10 | |
| 4445 | CDSN levels | PROLV000386 | 0.09 | Protein levels | Cutaneous epithelium | 146 | 1 | 8 | 7 | |
| 4446 | LECT2 levels | PROLV001196 | 0.09 | Protein levels | Hepatocyte | 66 | 1 | 6 | 7 | |
| 4447 | Cardiac strain rate | CARDI000006 | 0.09 | Cardiac | Muscle / cardiac | 0 | 2 | 3 | 5 | |
| 4448 | DBNL/VASH1 ratio | PRORT000869 | 0.09 | Protein ratios | Muscle / cardiac | 0 | 2 | 9 | 14 | |
| 4449 | Gastrointestinal polyps | GASTR000005 | 0.09 | Gastrointestinal | Respiratory epithelium | 0 | 0 | 4 | 11 | |
| 4450 | Intraocular pressure | OPHTH000011 | 0.09 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 4451 | IFIH1 levels | PROLV001015 | 0.09 | Protein levels | Vascular | 0 | 2 | 7 | 7 | |
| 4452 | CNDP1/F9 ratio | PRORT000678 | 0.09 | Protein ratios | Hepatocyte | 68 | 1 | 9 | 4 | |
| 4453 | GRPEL1/MME ratio | PRORT001248 | 0.09 | Protein ratios | Hepatocyte | 24 | 1 | 6 | 6 | |
| 4454 | ODAM levels | PROLV001462 | 0.09 | Protein levels | Salivary epithelium | 0 | 0 | 3 | 5 | |
| 4455 | ABL1/CC2D1A ratio | PRORT000008 | 0.09 | Protein ratios | Lymphocyte | 4 | 1 | 7 | 21 | |
| 4456 | CNTNAP2/DPP6 ratio | PRORT000690 | 0.09 | Protein ratios | Neural / glial | 0 | 2 | 13 | 27 | |
| 4457 | Sexual behaviour | BEHAV000012 | 0.09 | Behavioural | Neural / glial | 200 | 5 | 8 | 22 | |
| 4458 | Venous insufficiency | VASCU000065 | 0.09 | Vascular | Neural / glial | 1 | 1 | 4 | 12 | |
| 4459 | Suicidal behaviour | PSYCH000037 | 0.09 | Psychiatric | Neural / glial | 0 | 4 | 8 | 14 | |
| 4460 | GRAP2/LACTB2 ratio | PRORT001240 | 0.09 | Protein ratios | Hepatocyte | 5 | 3 | 7 | 13 | |
| 4461 | BPIFB2 levels | PROLV000211 | 0.09 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 4462 | PIK3AP1/PSMG3 ratio | PRORT001664 | 0.09 | Protein ratios | Lymphocyte | 1 | 1 | 6 | 9 | |
| 4463 | MIF/PARK7 ratio | PRORT001534 | 0.09 | Protein ratios | Stromal / connective | 0 | 0 | 9 | 8 | |
| 4464 | Supplement use, glucosamine | DTSUP000025 | 0.09 | Diet and Supplement | Neural / glial | 0 | 2 | 7 | 19 | |
| 4465 | CRADD/FADD ratio | PRORT000745 | 0.08 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 8 | 7 | |
| 4466 | CDH2/CDHR2 ratio | PRORT000552 | 0.08 | Protein ratios | Hepatocyte | 39 | 1 | 6 | 11 | |
| 4467 | LRP11/NECTIN2 ratio | PRORT001460 | 0.08 | Protein ratios | Vascular | 14 | 2 | 10 | 10 | |
| 4468 | EGF/MPIG6B ratio | PRORT000997 | 0.08 | Protein ratios | Myeloid | 1 | 3 | 12 | 21 | |
| 4469 | MRAP levels | PROLV001337 | 0.08 | Protein levels | Neural / glial | 0 | 4 | 5 | 19 | |
| 4470 | CASP10/ING1 ratio | PRORT000311 | 0.08 | Protein ratios | Lymphocyte | 4 | 3 | 11 | 36 | |
| 4471 | REG1B/REG3A ratio | PRORT001732 | 0.08 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 4472 | PTPRN2 levels | PROLV001679 | 0.08 | Protein levels | Pancreatic epithelium | 1 | 0 | 3 | 3 | |
| 4473 | ProBNP | CARDI000002 | 0.08 | Cardiac | B / plasma cell | 0 | 3 | 5 | 16 | |
| 4474 | Gastro-oesophageal reflux disease, GERD | GASTR000045 | 0.08 | Gastrointestinal | Neural / glial | 38 | 2 | 8 | 15 | |
| 4475 | Diabetes, type 2 with complication | METBL000033 | 0.08 | Metabolic | Neural / glial | 118 | 2 | 8 | 8 | |
| 4476 | Medication, post-myocardial infarction | CARDI000045 | 0.08 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 4477 | NECTIN4 levels | PROLV001388 | 0.08 | Protein levels | Renal epithelium | 51 | 0 | 9 | 7 | |
| 4478 | RNASE4 levels | PROLV001739 | 0.08 | Protein levels | Hepatocyte | 43 | 2 | 7 | 16 | |
| 4479 | ECG QRS-T angle | CARDI000033 | 0.08 | Cardiac | Muscle / cardiac | 57 | 2 | 4 | 10 | |
| 4480 | CA14 levels | PROLV000243 | 0.08 | Protein levels | Muscle / cardiac | 52 | 2 | 7 | 12 | |
| 4481 | ALPP levels | PROLV000083 | 0.08 | Protein levels | Respiratory epithelium | 12 | 0 | 11 | 19 | |
| 4482 | CD160/KLRB1 ratio | PRORT000377 | 0.08 | Protein ratios | Lymphocyte | 2 | 2 | 13 | 20 | |
| 4483 | SRC/STAT5B ratio | PRORT001813 | 0.08 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 22 | |
| 4484 | CKB levels | PROLV000440 | 0.08 | Protein levels | Muscle / cardiac | 40 | 3 | 5 | 15 | |
| 4485 | SFTPD levels | PROLV001849 | 0.08 | Protein levels | Vascular | 77 | 1 | 5 | 14 | |
| 4486 | IL15/NCR1 ratio | PRORT001344 | 0.08 | Protein ratios | Lymphocyte | 32 | 2 | 9 | 31 | |
| 4487 | APRT/NSFL1C ratio | PRORT000136 | 0.08 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 4488 | Bronchitis | RESPI000001 | 0.08 | Respiratory | Lymphocyte | 7 | 1 | 11 | 21 | |
| 4489 | MAPKAPK2 levels | PROLV001272 | 0.08 | Protein levels | Stromal / connective | 6 | 4 | 7 | 19 | |
| 4490 | Congenital cardiovascular malformations | CARDI000031 | 0.08 | Cardiac | Vascular | 0 | 4 | 10 | 28 | |
| 4491 | ARHGEF10 levels | PROLV000140 | 0.08 | Protein levels | Stromal / connective | 25 | 7 | 14 | 21 | |
| 4492 | Dietary change | DTSUP000006 | 0.08 | Diet and Supplement | Neural / glial | 13 | 3 | 7 | 0 | |
| 4493 | INSL5 levels | PROLV001093 | 0.08 | Protein levels | Hematopoietic progenitor | 10 | 1 | 5 | 7 | |
| 4494 | FADD/MGLL ratio | PRORT001105 | 0.08 | Protein ratios | Hematopoietic progenitor | 12 | 0 | 4 | 12 | |
| 4495 | Retinal vascular morphology | OPHTH000045 | 0.07 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 4496 | KDR/VWF ratio | PRORT001402 | 0.07 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 4497 | PDGFB/SPINT2 ratio | PRORT001646 | 0.07 | Protein ratios | Hepatocyte | 41 | 2 | 6 | 19 | |
| 4498 | AKR1B1 levels | PROLV000072 | 0.07 | Protein levels | Stromal / connective | 11 | 7 | 10 | 27 | |
| 4499 | PXN levels | PROLV001688 | 0.07 | Protein levels | Neural / glial | 9 | 4 | 16 | 37 | |
| 4500 | Wisdom tooth surgery | DENTA000005 | 0.07 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 4501 | TNFRSF12A levels | PROLV002062 | 0.07 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 4502 | Benign neoplasm, Uterus | MALIG000008 | 0.07 | Malignancy | Lymphocyte | 38 | 0 | 2 | 26 | |
| 4503 | Complement system disorder | IMMUN000048 | 0.07 | Immunologic | Hepatocyte | 4 | 1 | 5 | 8 | |
| 4504 | SUOX levels | PROLV001977 | 0.07 | Protein levels | Hepatocyte | 27 | 1 | 13 | 31 | |
| 4505 | EFNB2 levels | PROLV000683 | 0.07 | Protein levels | Hepatocyte | 9 | 0 | 3 | 6 | |
| 4506 | CDKN2D/MANF ratio | PRORT000579 | 0.07 | Protein ratios | Platelet | 12 | 3 | 5 | 11 | |
| 4507 | CA2/HMBS ratio | PRORT000275 | 0.07 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 4508 | MOCS2 levels | PROLV001331 | 0.07 | Protein levels | Stromal / connective | 8 | 1 | 3 | 21 | |
| 4509 | CKAP2 levels | PROLV000438 | 0.07 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 4510 | Cervical disorder | REPRO000001 | 0.07 | Reproductive | Stromal / connective | 8 | 2 | 9 | 19 | |
| 4511 | SEMA4D/TREML2 ratio | PRORT001771 | 0.07 | Protein ratios | Hematopoietic progenitor | 3 | 2 | 6 | 24 | |
| 4512 | Neoplasm, uncertain behaviour | MALIG000035 | 0.07 | Malignancy | Lymphocyte | 1 | 2 | 9 | 26 | |
| 4513 | CPA2 levels | PROLV000502 | 0.07 | Protein levels | Pancreatic epithelium | 57 | 0 | 5 | 5 | |
| 4514 | GLRX2 levels | PROLV000897 | 0.07 | Protein levels | Neural / glial | 0 | 2 | 6 | 17 | |
| 4515 | AGXT/GSTA1 ratio | PRORT000052 | 0.07 | Protein ratios | Hepatocyte | 24 | 1 | 7 | 7 | |
| 4516 | FADD/GRAP2 ratio | PRORT001103 | 0.07 | Protein ratios | Neural / glial | 1 | 3 | 6 | 9 | |
| 4517 | CA1 levels | PROLV000239 | 0.07 | Protein levels | Lymphocyte | 0 | 2 | 13 | 28 | |
| 4518 | EBAG9/FKBP5 ratio | PRORT000958 | 0.07 | Protein ratios | Lymphocyte | 1 | 5 | 8 | 24 | |
| 4519 | CELA3A/CPB1 ratio | PRORT000594 | 0.07 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 4520 | UROD levels | PROLV002143 | 0.07 | Protein levels | Lymphocyte | 2 | 2 | 9 | 33 | |
| 4521 | CXCL10/CXCL11 ratio | PRORT000814 | 0.07 | Protein ratios | Hematopoietic progenitor | 5 | 4 | 9 | 12 | |
| 4522 | AGRN/BTN2A1 ratio | PRORT000046 | 0.07 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 4523 | Prolapse, pelvic organ | REPRO000025 | 0.07 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 4524 | Chronic kidney disease | NEPHR000001 | 0.07 | Nephrourologic | Hepatocyte | 63 | 1 | 4 | 8 | |
| 4525 | CD27 levels | PROLV000324 | 0.07 | Protein levels | B / plasma cell | 60 | 3 | 16 | 24 | |
| 4526 | Atopic dermatitis | DERMA000006 | 0.07 | Dermatologic | Lymphocyte | 115 | 2 | 13 | 11 | |
| 4527 | ECG-predicted BMI discrepancy | BMORP000008 | 0.07 | Body morphology | Muscle / cardiac | 0 | 2 | 5 | 20 | |
| 4528 | Diverticular disease | GASTR000011 | 0.07 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 4529 | MPHOSPH8 levels | PROLV001333 | 0.07 | Protein levels | Myeloid | 8 | 2 | 5 | 12 | |
| 4530 | KIAA0319 levels | PROLV001137 | 0.07 | Protein levels | Respiratory epithelium | 15 | 0 | 6 | 14 | |
| 4531 | PYDC1 levels | PROLV001689 | 0.07 | Protein levels | Cutaneous epithelium | 85 | 2 | 9 | 10 | |
| 4532 | Personal medical history | MISCL000011 | 0.06 | Miscellaneous | Neural / glial | 0 | 0 | 3 | 7 | |
| 4533 | CFC1 levels | PROLV000411 | 0.06 | Protein levels | Hematopoietic progenitor | 4 | 1 | 3 | 5 | |
| 4534 | Medication, coronary artery disease | VASCU000037 | 0.06 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 4535 | TNFRSF21 levels | PROLV002070 | 0.06 | Protein levels | Renal epithelium | 63 | 0 | 9 | 14 | |
| 4536 | Medication, diuretic | VASCU000038 | 0.06 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 4537 | Liver iron content | HPBIL000024 | 0.06 | Hepatopancreatobiliary | Hematopoietic progenitor | 23 | 1 | 9 | 14 | |
| 4538 | TAB2 levels | PROLV001987 | 0.06 | Protein levels | Myeloid | 0 | 2 | 3 | 9 | |
| 4539 | SPON1 levels | PROLV001936 | 0.06 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 4540 | LGALS7 or LGALS7B levels | PROLV001205 | 0.06 | Protein levels | Respiratory epithelium | 79 | 1 | 11 | 12 | |
| 4541 | Pre-existing hypertension, pregnancy | VASCU000044 | 0.06 | Vascular | B / plasma cell | 9 | 3 | 8 | 20 | |
| 4542 | UCMA levels | PROLV002135 | 0.06 | Protein levels | Lymphocyte | 0 | 5 | 11 | 34 | |
| 4543 | FAM172A levels | PROLV000762 | 0.06 | Protein levels | Stromal / connective | 9 | 2 | 9 | 24 | |
| 4544 | IRAK1/SPRY2 ratio | PRORT001369 | 0.06 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 4545 | Retinal detachments and defects | OPHTH000039 | 0.06 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 4546 | Magnesium | METAB000047 | 0.06 | Metabolites | Renal epithelium | 35 | 0 | 4 | 8 | |
| 4547 | Gastrointestinal endoscopy | GASTR000042 | 0.06 | Gastrointestinal | Neural / glial | 13 | 2 | 8 | 11 | |
| 4548 | Gut microbial abundance, CAG-776 | GASTR000023 | 0.06 | Gastrointestinal | Neural / glial | 0 | 2 | 4 | 16 | |
| 4549 | AGER levels | PROLV000054 | 0.06 | Protein levels | Vascular | 97 | 1 | 7 | 11 | |
| 4550 | CHCHD6 levels | PROLV000425 | 0.06 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 4551 | Male-pattern baldness | DERMA000032 | 0.06 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 4552 | SPINK5/SPINT1 ratio | PRORT001809 | 0.06 | Protein ratios | Gastrointestinal epithelium | 11 | 0 | 10 | 4 | |
| 4553 | ING1 levels | PROLV001086 | 0.06 | Protein levels | Vascular | 0 | 3 | 8 | 26 | |
| 4554 | PDIA4 levels | PROLV001527 | 0.06 | Protein levels | Stromal / connective | 5 | 2 | 5 | 12 | |
| 4555 | CDH5/PEAR1 ratio | PRORT000560 | 0.06 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 30 | |
| 4556 | SEZ6 levels | PROLV001840 | 0.06 | Protein levels | Neural / glial | 1 | 3 | 9 | 20 | |
| 4557 | CDH3 levels | PROLV000375 | 0.06 | Protein levels | Renal epithelium | 40 | 0 | 5 | 5 | |
| 4558 | LAYN levels | PROLV001187 | 0.06 | Protein levels | Granulosa cell | 91 | 0 | 5 | 3 | |
| 4559 | DSG3/SPINK5 ratio | PRORT000955 | 0.06 | Protein ratios | Cutaneous epithelium | 43 | 0 | 12 | 10 | |
| 4560 | CPXM1/VEGFC ratio | PRORT000737 | 0.06 | Protein ratios | Hematopoietic progenitor | 21 | 2 | 3 | 15 | |
| 4561 | GPKOW levels | PROLV000925 | 0.06 | Protein levels | Muscle / cardiac | 5 | 4 | 5 | 17 | |
| 4562 | BTD levels | PROLV000218 | 0.06 | Protein levels | Hepatocyte | 77 | 3 | 11 | 13 | |
| 4563 | Blood pressure, BP, diastolic | VASCU000009 | 0.06 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 4564 | ANKRD54 levels | PROLV000101 | 0.06 | Protein levels | Vascular | 2 | 2 | 4 | 18 | |
| 4565 | Cardiac angiography | CARDI000047 | 0.06 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 4566 | ERBB4/F3 ratio | PRORT001046 | 0.06 | Protein ratios | B / plasma cell | 8 | 2 | 8 | 28 | |
| 4567 | PALM2 levels | PROLV001490 | 0.06 | Protein levels | Lymphocyte | 22 | 4 | 19 | 36 | |
| 4568 | Cutaneous abscess | IMMUN000057 | 0.06 | Immunologic | Neural / glial | 0 | 2 | 7 | 15 | |
| 4569 | PRKAR2A levels | PROLV001632 | 0.06 | Protein levels | Myeloid | 15 | 3 | 5 | 18 | |
| 4570 | Nephritis and nephropathy | NEPHR000010 | 0.06 | Nephrourologic | Muscle / cardiac | 0 | 1 | 4 | 7 | |
| 4571 | ATRAID levels | PROLV000162 | 0.06 | Protein levels | Granulosa cell | 4 | 0 | 5 | 9 | |
| 4572 | Heart failure, with coronary heart disease | CARDI000005 | 0.06 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 4573 | GP6/SEMA4D ratio | PRORT001236 | 0.06 | Protein ratios | Hepatocyte | 16 | 6 | 13 | 17 | |
| 4574 | LEFTY2 levels | PROLV001197 | 0.06 | Protein levels | Hepatocyte | 76 | 2 | 8 | 12 | |
| 4575 | CTRC/PLA2G1B ratio | PRORT000797 | 0.06 | Protein ratios | Epithelial | 43 | 1 | 2 | 8 | |
| 4576 | Phosphatidates | LIPID000057 | 0.06 | Lipids | Melanocyte | 0 | 1 | 2 | 4 | |
| 4577 | SCARA5 levels | PROLV001780 | 0.06 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 4578 | Secondary arthropathy | MSKEL000021 | 0.06 | Musculoskeletal | Hepatocyte | — | 2 | 9 | 13 | |
| 4579 | ITGB1BP2/PTPN6 ratio | PRORT001386 | 0.06 | Protein ratios | Hematopoietic progenitor | 21 | 6 | 14 | 34 | |
| 4580 | LGALS4 levels | PROLV001204 | 0.06 | Protein levels | B / plasma cell | 26 | 1 | 9 | 12 | |
| 4581 | ADD1 levels | PROLV000039 | 0.05 | Protein levels | Lymphocyte | 1 | 1 | 9 | 31 | |
| 4582 | LRPAP1 levels | PROLV001231 | 0.05 | Protein levels | Vascular | 92 | 3 | 8 | 20 | |
| 4583 | HAMP levels | PROLV000950 | 0.05 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 4584 | Bone mineral density, childhood | MSKEL000003 | 0.05 | Musculoskeletal | Muscle / cardiac | 1 | 1 | 6 | 5 | |
| 4585 | Self-rated health | MISCL000013 | 0.05 | Miscellaneous | Neural / glial | 29 | 5 | 10 | 17 | |
| 4586 | Nutritional and metabolic symptoms | METBL000016 | 0.05 | Metabolic | Lymphocyte | 0 | 4 | 7 | 28 | |
| 4587 | Transient ischaemic attack | VASCU000019 | 0.05 | Vascular | Vascular | 0 | 0 | 3 | 4 | |
| 4588 | RGMB levels | PROLV001729 | 0.05 | Protein levels | Neural / glial | 21 | 1 | 6 | 7 | |
| 4589 | Erectile dysfunction | VASCU000048 | 0.05 | Vascular | Neural / glial | 0 | 4 | 5 | 15 | |
| 4590 | CRACR2A levels | PROLV000515 | 0.05 | Protein levels | Myeloid | 3 | 2 | 9 | 17 | |
| 4591 | Skin keratoses, seborrhoeic | DERMA000022 | 0.05 | Dermatologic | Hepatocyte | 13 | 1 | 12 | 26 | |
| 4592 | Fracture fixation | MSKEL000047 | 0.05 | Musculoskeletal | B / plasma cell | 0 | 2 | 9 | 16 | |
| 4593 | ELAC1 levels | PROLV000699 | 0.05 | Protein levels | Lymphocyte | 2 | 3 | 8 | 33 | |
| 4594 | CNPY4/STAT5B ratio | PRORT000681 | 0.05 | Protein ratios | Hepatocyte | 2 | 3 | 12 | 17 | |
| 4595 | Demyelinating disorder | NEURO000005 | 0.05 | Neurologic | Lymphocyte | — | 2 | 15 | 26 | |
| 4596 | CNTNAP2/DPP10 ratio | PRORT000689 | 0.05 | Protein ratios | Vascular | 0 | 1 | 4 | 9 | |
| 4597 | REG1A/REG3A ratio | PRORT001729 | 0.05 | Protein ratios | Gastrointestinal epithelium | 34 | 0 | 6 | 7 | |
| 4598 | DLG4 levels | PROLV000624 | 0.05 | Protein levels | Lymphocyte | 5 | 1 | 5 | 33 | |
| 4599 | Medication, antispasmodic | GASTR000015 | 0.05 | Gastrointestinal | Lymphocyte | 0 | 3 | 9 | 27 | |
| 4600 | Cancer, Colorectal | MALIG000013 | 0.05 | Malignancy | Epithelial | 27 | 0 | 3 | 2 | |
| 4601 | CST1 levels | PROLV000548 | 0.05 | Protein levels | Salivary epithelium | 31 | 0 | 12 | 11 | |
| 4602 | OCLN levels | PROLV001461 | 0.05 | Protein levels | Lymphocyte | 0 | 3 | 6 | 39 | |
| 4603 | Urolithiasis | NEPHR000026 | 0.05 | Nephrourologic | Epithelial | 279 | 1 | 6 | 12 | |
| 4604 | PILRB levels | PROLV001561 | 0.05 | Protein levels | Myeloid | 43 | 2 | 6 | 10 | |
| 4605 | IRF2 levels | PROLV001099 | 0.05 | Protein levels | Hepatocyte | 0 | 2 | 5 | 19 | |
| 4606 | NBL1/TGFBR2 ratio | PRORT001573 | 0.05 | Protein ratios | Vascular | 18 | 1 | 7 | 15 | |
| 4607 | IL15 levels | PROLV001048 | 0.05 | Protein levels | Lymphocyte | 114 | 2 | 12 | 20 | |
| 4608 | SYAP1 levels | PROLV001984 | 0.05 | Protein levels | Platelet | 11 | 3 | 5 | 18 | |
| 4609 | VSIG10 levels | PROLV002169 | 0.05 | Protein levels | Muscle / cardiac | 3 | 1 | 4 | 7 | |
| 4610 | Ovarian cyst | REPRO000022 | 0.05 | Reproductive | Pancreatic epithelium | 32 | 0 | 5 | 7 | |
| 4611 | Bleeding gums | DENTA000011 | 0.05 | Dental | Lymphocyte | 0 | 0 | 12 | 15 | |
| 4612 | CEACAM8/RNASE3 ratio | PRORT000589 | 0.05 | Protein ratios | Hematopoietic progenitor | 2 | 3 | 4 | 11 | |
| 4613 | Ventricular outflow tract obstruction | CARDI000032 | 0.05 | Cardiac | Muscle / cardiac | 0 | 2 | 13 | 27 | |
| 4614 | NMT1 levels | PROLV001412 | 0.05 | Protein levels | Neural / glial | 0 | 4 | 14 | 26 | |
| 4615 | Erythematosquamous dermatosis | DERMA000009 | 0.05 | Dermatologic | Lymphocyte | 92 | 2 | 19 | 20 | |
| 4616 | Lymphangioleiomyomatosis | RESPI000014 | 0.05 | Respiratory | Muscle / cardiac | 0 | 3 | 7 | 25 | |
| 4617 | Isoleucine | METAB000024 | 0.05 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 4618 | Body fat percentage, hormone-adjusted | BCOMP000001 | 0.05 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 4619 | FGF21 levels | PROLV000795 | 0.05 | Protein levels | Hepatocyte | 41 | 2 | 4 | 5 | |
| 4620 | Medication, anti-arrhythmic | CARDI000043 | 0.05 | Cardiac | Neural / glial | 5 | 3 | 10 | 22 | |
| 4621 | SPINK5 levels | PROLV001930 | 0.05 | Protein levels | Renal epithelium | 10 | 1 | 14 | 20 | |
| 4622 | Consultant specialty, ophthalmology | MISCL000018 | 0.05 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 4623 | BCL2L1 levels | PROLV000186 | 0.05 | Protein levels | Myeloid | 28 | 3 | 6 | 13 | |
| 4624 | TBCC/WWP2 ratio | PRORT001828 | 0.05 | Protein ratios | Muscle / cardiac | 0 | 3 | 10 | 15 | |
| 4625 | CELA3A/CTRB1 ratio | PRORT000595 | 0.04 | Protein ratios | Vascular | 12 | 2 | 6 | 9 | |
| 4626 | NFE2 levels | PROLV001397 | 0.04 | Protein levels | Stromal / connective | 10 | 2 | 5 | 12 | |
| 4627 | HSPG2 levels | PROLV000999 | 0.04 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 4628 | Proline | METAB000028 | 0.04 | Metabolites | Cutaneous epithelium | 0 | 0 | 4 | 5 | |
| 4629 | DAG1/GP6 ratio | PRORT000847 | 0.04 | Protein ratios | Myeloid | 1 | 2 | 7 | 11 | |
| 4630 | Urinary incontinence | NEPHR000014 | 0.04 | Nephrourologic | Epithelial | 1 | 1 | 9 | 9 | |
| 4631 | CRTAM/FCRL6 ratio | PRORT000768 | 0.04 | Protein ratios | Lymphocyte | 37 | 2 | 12 | 22 | |
| 4632 | Medication, anti-depressant | PSYCH000019 | 0.04 | Psychiatric | Neural / glial | 5 | 3 | 8 | 8 | |
| 4633 | PTPN1 levels | PROLV001671 | 0.04 | Protein levels | Vascular | 7 | 4 | 7 | 22 | |
| 4634 | Radiotherapy | MALIG000049 | 0.04 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 4635 | CD27/TGFBR2 ratio | PRORT000417 | 0.04 | Protein ratios | B / plasma cell | 29 | 3 | 10 | 19 | |
| 4636 | Kidney cyst | NEPHR000004 | 0.04 | Nephrourologic | Stromal / connective | 12 | 1 | 6 | 13 | |
| 4637 | BCAM/LGALS4 ratio | PRORT000210 | 0.04 | Protein ratios | Hepatocyte | 31 | 1 | 7 | 4 | |
| 4638 | ARL13B levels | PROLV000143 | 0.04 | Protein levels | Stromal / connective | 0 | 1 | 5 | 10 | |
| 4639 | SNRPB2 levels | PROLV001910 | 0.04 | Protein levels | Lymphocyte | 0 | 4 | 12 | 34 | |
| 4640 | UBE2L6 levels | PROLV002133 | 0.04 | Protein levels | Stromal / connective | 2 | 3 | 9 | 31 | |
| 4641 | CLEC14A/PTPRS ratio | PRORT000628 | 0.04 | Protein ratios | Vascular | 0 | 0 | 4 | 8 | |
| 4642 | Thrombophlebitis | VASCU000063 | 0.04 | Vascular | Hepatocyte | 61 | 1 | 4 | 9 | |
| 4643 | CA9/CBLIF ratio | PRORT000290 | 0.04 | Protein ratios | Pancreatic epithelium | 47 | 0 | 4 | 7 | |
| 4644 | NTPROBNP levels | PROLV001446 | 0.04 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 4645 | ESAM/LAMA4 ratio | PRORT001063 | 0.04 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 4646 | BTN2A1 levels | PROLV000219 | 0.04 | Protein levels | Renal epithelium | 90 | 0 | 5 | 4 | |
| 4647 | FGFR2/TGFBR2 ratio | PRORT001142 | 0.04 | Protein ratios | Hepatocyte | 21 | 1 | 9 | 12 | |
| 4648 | Open wound | DERMA000043 | 0.04 | Dermatologic | Neural / glial | 1 | 3 | 7 | 6 | |
| 4649 | CCL28/PDGFB ratio | PRORT000354 | 0.04 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 6 | 27 | |
| 4650 | NPDC1/PTGDS ratio | PRORT001594 | 0.04 | Protein ratios | Vascular | 0 | 2 | 12 | 34 | |
| 4651 | PI3 levels | PROLV001554 | 0.04 | Protein levels | Cutaneous epithelium | 5 | 1 | 8 | 8 | |
| 4652 | PROK2 levels | PROLV001639 | 0.04 | Protein levels | Hepatocyte | 4 | 4 | 9 | 11 | |
| 4653 | Joint injection | MSKEL000048 | 0.04 | Musculoskeletal | Neural / glial | 0 | 5 | 14 | 36 | |
| 4654 | Medication, anti-malarial | IMMUN000083 | 0.04 | Immunologic | Neural / glial | 0 | 2 | 6 | 16 | |
| 4655 | ABHD14B/SCRN1 ratio | PRORT000006 | 0.04 | Protein ratios | Hematopoietic progenitor | 1 | 2 | 7 | 10 | |
| 4656 | DBN1 levels | PROLV000598 | 0.04 | Protein levels | Myeloid | 0 | 3 | 5 | 9 | |
| 4657 | NRCAM/PCDH17 ratio | PRORT001598 | 0.04 | Protein ratios | Hematopoietic progenitor | 0 | 3 | 5 | 13 | |
| 4658 | CST6 levels | PROLV000551 | 0.04 | Protein levels | Cutaneous epithelium | 33 | 1 | 10 | 10 | |
| 4659 | THY1 levels | PROLV002031 | 0.04 | Protein levels | B / plasma cell | 30 | 2 | 10 | 21 | |
| 4660 | CTRL levels | PROLV000559 | 0.04 | Protein levels | Hepatocyte | 128 | 1 | 3 | 7 | |
| 4661 | PSPN levels | PROLV001661 | 0.04 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 4662 | LAMB1 levels | PROLV001179 | 0.04 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 4663 | Wheeze | RESPI000034 | 0.04 | Respiratory | Lymphocyte | 80 | 2 | 12 | 20 | |
| 4664 | TRIM21 levels | PROLV002106 | 0.04 | Protein levels | Stromal / connective | 22 | 1 | 6 | 17 | |
| 4665 | SPINK6 levels | PROLV001931 | 0.04 | Protein levels | Cutaneous epithelium | 0 | 1 | 13 | 10 | |
| 4666 | PDE5A levels | PROLV001520 | 0.04 | Protein levels | Muscle / cardiac | 19 | 2 | 8 | 18 | |
| 4667 | CMIP levels | PROLV000470 | 0.04 | Protein levels | Stromal / connective | 1 | 2 | 6 | 11 | |
| 4668 | CCL11/CCL2 ratio | PRORT000335 | 0.04 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 4669 | Male genital disorder | REPRO000013 | 0.04 | Reproductive | Granulosa cell | 7 | 0 | 7 | 9 | |
| 4670 | CASP7 levels | PROLV000269 | 0.04 | Protein levels | Stromal / connective | 10 | 4 | 10 | 19 | |
| 4671 | Anal and rectal disorder | GASTR000001 | 0.03 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 4672 | DOK2/GRAP2 ratio | PRORT000938 | 0.03 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 4 | 7 | |
| 4673 | GLA levels | PROLV000893 | 0.03 | Protein levels | Lymphocyte | 2 | 3 | 6 | 30 | |
| 4674 | CD99/MMP3 ratio | PRORT000535 | 0.03 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 4675 | Medication use, pain etc, none | MISCL000032 | 0.03 | Miscellaneous | Neural / glial | 13 | 4 | 10 | 4 | |
| 4676 | HDAC8 levels | PROLV000958 | 0.03 | Protein levels | B / plasma cell | — | 1 | 12 | 24 | |
| 4677 | GZMB/IL15 ratio | PRORT001263 | 0.03 | Protein ratios | Lymphocyte | 36 | 2 | 13 | 20 | |
| 4678 | GPA33 levels | PROLV000918 | 0.03 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 4679 | APPL2 levels | PROLV000130 | 0.03 | Protein levels | Stromal / connective | 3 | 2 | 5 | 8 | |
| 4680 | USP25 levels | PROLV002145 | 0.03 | Protein levels | Stromal / connective | 1 | 2 | 5 | 19 | |
| 4681 | ANXA3/BID ratio | PRORT000104 | 0.03 | Protein ratios | Hepatocyte | 22 | 1 | 5 | 7 | |
| 4682 | Nummular dermatitis | DERMA000014 | 0.03 | Dermatologic | Vascular | 0 | 0 | 2 | 5 | |
| 4683 | THY1/TNFRSF21 ratio | PRORT001836 | 0.03 | Protein ratios | Lymphocyte | 1 | 1 | 4 | 6 | |
| 4684 | Hydrocephalus | NEURO000002 | 0.03 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 4685 | Tuberculosis, TB | IMMUN000050 | 0.03 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 4686 | Spondylosis | MSKEL000081 | 0.03 | Musculoskeletal | Stromal / connective | 9 | 3 | 7 | 18 | |
| 4687 | PDGFB/SPARC ratio | PRORT001645 | 0.03 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 4688 | GM2A levels | PROLV000900 | 0.03 | Protein levels | Muscle / cardiac | 16 | 0 | 6 | 7 | |
| 4689 | Amino sugar metabolites | METAB000034 | 0.03 | Metabolites | Lymphocyte | 0 | 1 | 5 | 20 | |
| 4690 | Urate | METAB000064 | 0.03 | Metabolites | Epithelial | 1,143 | 1 | 6 | 9 | |
| 4691 | CACYBP levels | PROLV000252 | 0.03 | Protein levels | Platelet | 2 | 4 | 7 | 21 | |
| 4692 | Medication, vasodilators | VASCU000041 | 0.03 | Vascular | Vascular | 3 | 2 | 5 | 5 | |
| 4693 | VASP levels | PROLV002152 | 0.03 | Protein levels | Lymphocyte | 2 | 3 | 7 | 21 | |
| 4694 | BACH1/SNX9 ratio | PRORT000199 | 0.03 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 11 | |
| 4695 | Ganglion cell inner plexiform layer thickness | OPHTH000027 | 0.03 | Ophthalmic | Renal epithelium | 10 | 0 | 6 | 5 | |
| 4696 | Diabetes, general | METBL000030 | 0.03 | Metabolic | Hepatocyte | 973 | 1 | 5 | 8 | |
| 4697 | MARS1 levels | PROLV001275 | 0.03 | Protein levels | Stromal / connective | 0 | 3 | 6 | 20 | |
| 4698 | CCBL2 levels | PROLV000274 | 0.03 | Protein levels | Neural / glial | 0 | 0 | 7 | 13 | |
| 4699 | AGXT/GRPEL1 ratio | PRORT000051 | 0.03 | Protein ratios | Hepatocyte | 44 | 2 | 5 | 11 | |
| 4700 | LY6D/NECTIN4 ratio | PRORT001468 | 0.03 | Protein ratios | Cutaneous epithelium | 13 | 0 | 8 | 11 | |
| 4701 | INSL4 levels | PROLV001092 | 0.03 | Protein levels | Muscle / cardiac | 3 | 2 | 4 | 12 | |
| 4702 | Medication, proton pump inhibitor | GASTR000017 | 0.03 | Gastrointestinal | Neural / glial | 0 | 3 | 7 | 21 | |
| 4703 | CABP2 levels | PROLV000249 | 0.03 | Protein levels | B / plasma cell | 21 | 2 | 4 | 10 | |
| 4704 | Retinal thickness | OPHTH000043 | 0.03 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 4705 | Sodium | METAB000050 | 0.03 | Metabolites | Neural / glial | 189 | 3 | 8 | 9 | |
| 4706 | Financial satisfaction | SOCIO000024 | 0.03 | Socioeconomic | Neural / glial | 0 | 2 | 8 | 18 | |
| 4707 | Choroid plexus volume | NIMAG000020 | 0.03 | Neuroimaging | Neural / glial | 0 | 0 | 1 | 3 | |
| 4708 | Medication, insulin therapy | METBL000027 | 0.03 | Metabolic | Hematopoietic progenitor | 22 | 1 | 5 | 11 | |
| 4709 | SNAP29/SNX9 ratio | PRORT001797 | 0.03 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 28 | |
| 4710 | XPNPEP2 levels | PROLV002199 | 0.03 | Protein levels | Hepatocyte | 67 | 2 | 9 | 14 | |
| 4711 | GAPDH levels | PROLV000853 | 0.03 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 4712 | CD93/CLEC14A ratio | PRORT000531 | 0.03 | Protein ratios | Neural / glial | 3 | 2 | 8 | 17 | |
| 4713 | KLF4 levels | PROLV001149 | 0.03 | Protein levels | Lymphocyte | 0 | 2 | 7 | 21 | |
| 4714 | Enamel hypoplasia | DENTA000002 | 0.03 | Dental | Vascular | 0 | 0 | 13 | 48 | |
| 4715 | NEXN levels | PROLV001393 | 0.03 | Protein levels | Vascular | 1 | 2 | 3 | 9 | |
| 4716 | FADD/LACTB2 ratio | PRORT001104 | 0.03 | Protein ratios | Hematopoietic progenitor | 1 | 1 | 8 | 6 | |
| 4717 | ITGB1/SELP ratio | PRORT001380 | 0.03 | Protein ratios | Granulosa cell | 3 | 1 | 4 | 14 | |
| 4718 | CETN3 levels | PROLV000409 | 0.03 | Protein levels | Platelet | 15 | 3 | 5 | 14 | |
| 4719 | CDH5/NOTCH1 ratio | PRORT000558 | 0.03 | Protein ratios | Vascular | 22 | 2 | 9 | 12 | |
| 4720 | CR2/TNFRSF13B ratio | PRORT000738 | 0.03 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 4721 | CCDC50 levels | PROLV000275 | 0.03 | Protein levels | B / plasma cell | 0 | 4 | 7 | 12 | |
| 4722 | HS1BP3 levels | PROLV000989 | 0.03 | Protein levels | Stromal / connective | 24 | 6 | 12 | 24 | |
| 4723 | Urinary retention | NEPHR000015 | 0.03 | Nephrourologic | Lymphocyte | 0 | 0 | 1 | 5 | |
| 4724 | AHSP levels | PROLV000066 | 0.03 | Protein levels | Muscle / cardiac | 0 | 1 | 4 | 13 | |
| 4725 | Intestinal infection | IMMUN000066 | 0.03 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 4726 | Arterial disease | VASCU000023 | 0.03 | Vascular | Vascular | 66 | 3 | 10 | 16 | |
| 4727 | Waist circumference, adjusted for BMI | BMORP000006 | 0.03 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 4728 | Family history, diabetes | METBL000009 | 0.03 | Metabolic | Hematopoietic progenitor | 0 | 1 | 1 | 5 | |
| 4729 | FOXO3/MAP3K5 ratio | PRORT001178 | 0.03 | Protein ratios | Gastrointestinal epithelium | 0 | 1 | 11 | 19 | |
| 4730 | RAP1A levels | PROLV001704 | 0.03 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 4731 | Diabetes, with complication | METBL000035 | 0.03 | Metabolic | Neural / glial | 74 | 1 | 4 | 9 | |
| 4732 | Medication, antihypertensive | VASCU000031 | 0.03 | Vascular | Vascular | 332 | 2 | 4 | 9 | |
| 4733 | Iron | METAB000046 | 0.03 | Metabolites | Muscle / cardiac | 0 | 1 | 7 | 14 | |
| 4734 | PLXDC1 levels | PROLV001583 | 0.03 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 4735 | ELOA/POLR2F ratio | PRORT001016 | 0.03 | Protein ratios | Muscle / cardiac | 0 | 3 | 16 | 28 | |
| 4736 | BCR/FOXO1 ratio | PRORT000224 | 0.03 | Protein ratios | Hepatocyte | 15 | 3 | 12 | 23 | |
| 4737 | Benign neoplasm, Colorectal | MALIG000002 | 0.03 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 4738 | Pulmonary nodule | RESPI000018 | 0.03 | Respiratory | Lymphocyte | 2 | 3 | 19 | 36 | |
| 4739 | TNC/VCAM1 ratio | PRORT001843 | 0.03 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 4740 | Housing tenure | SOCIO000012 | 0.03 | Socioeconomic | Neural / glial | 0 | 5 | 9 | 20 | |
| 4741 | MTSS1 levels | PROLV001349 | 0.03 | Protein levels | Vascular | 14 | 4 | 6 | 7 | |
| 4742 | Cervicobrachial syndrome | MSKEL000073 | 0.03 | Musculoskeletal | Muscle / cardiac | 0 | 3 | 8 | 15 | |
| 4743 | Ankle spacing width | MSKEL000056 | 0.03 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 4744 | Tryptophan | METAB000030 | 0.03 | Metabolites | Hepatocyte | 4 | 2 | 6 | 16 | |
| 4745 | Medication, musculoskeletal | MSKEL000026 | 0.03 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 5 | |
| 4746 | KIFBP/TACC3 ratio | PRORT001404 | 0.03 | Protein ratios | Hematopoietic progenitor | 3 | 1 | 4 | 6 | |
| 4747 | NPDC1 levels | PROLV001420 | 0.03 | Protein levels | Vascular | 9 | 0 | 8 | 13 | |
| 4748 | IGFBP2 levels | PROLV001029 | 0.03 | Protein levels | Muscle / cardiac | 58 | 2 | 4 | 14 | |
| 4749 | NBL1 levels | PROLV001375 | 0.03 | Protein levels | Renal epithelium | 28 | 0 | 4 | 2 | |
| 4750 | GNPDA2 levels | PROLV000906 | 0.03 | Protein levels | Lymphocyte | 0 | 3 | 2 | 7 | |
| 4751 | CPB1/PRSS2 ratio | PRORT000727 | 0.03 | Protein ratios | Granulosa cell | 22 | 0 | 1 | 6 | |
| 4752 | C1QTNF1/COL4A1 ratio | PRORT000263 | 0.03 | Protein ratios | Granulosa cell | 30 | 2 | 5 | 14 | |
| 4753 | GPKOW/PXN ratio | PRORT001239 | 0.03 | Protein ratios | Myeloid | 0 | 1 | 5 | 9 | |
| 4754 | CDH5/PCDH17 ratio | PRORT000559 | 0.03 | Protein ratios | Vascular | 23 | 2 | 8 | 6 | |
| 4755 | Digestive system symptoms | GASTR000044 | 0.03 | Gastrointestinal | Neural / glial | 9 | 4 | 10 | 35 | |
| 4756 | PCDH12 levels | PROLV001505 | 0.03 | Protein levels | Neural / glial | 5 | 2 | 5 | 10 | |
| 4757 | Social and economic stability | SOCIO000028 | 0.03 | Socioeconomic | Neural / glial | 0 | 4 | 7 | 26 | |
| 4758 | CD99 levels | PROLV000363 | 0.02 | Protein levels | Granulosa cell | 27 | 1 | 7 | 9 | |
| 4759 | TCTN3 levels | PROLV002005 | 0.02 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 4760 | LACRT levels | PROLV001173 | 0.02 | Protein levels | Cutaneous epithelium | 32 | 1 | 8 | 13 | |
| 4761 | FSTL3/SPON2 ratio | PRORT001182 | 0.02 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 4762 | MST1 levels | PROLV001344 | 0.02 | Protein levels | Hepatocyte | 131 | 3 | 6 | 10 | |
| 4763 | CLEC14A levels | PROLV000446 | 0.02 | Protein levels | Renal epithelium | 52 | 0 | 7 | 7 | |
| 4764 | TFF3 levels | PROLV002014 | 0.02 | Protein levels | Pancreatic epithelium | 24 | 0 | 3 | 5 | |
| 4765 | Pregnancy complication, vomiting | REPRO000035 | 0.02 | Reproductive | Lymphocyte | 0 | 1 | 8 | 25 | |
| 4766 | LRP11 levels | PROLV001230 | 0.02 | Protein levels | Vascular | 22 | 0 | 8 | 22 | |
| 4767 | ULBP2 levels | PROLV002139 | 0.02 | Protein levels | Granulosa cell | 11 | 0 | 4 | 7 | |
| 4768 | Cancer, Cervix | MALIG000012 | 0.02 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 4769 | COL18A1 levels | PROLV000484 | 0.02 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 4770 | ANKMY2 levels | PROLV000100 | 0.02 | Protein levels | Stromal / connective | 7 | 3 | 7 | 9 | |
| 4771 | CELSR2 levels | PROLV000398 | 0.02 | Protein levels | Muscle / cardiac | 14 | 2 | 9 | 15 | |
| 4772 | Cataract | OPHTH000012 | 0.02 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 4773 | SLC27A4 levels | PROLV001878 | 0.02 | Protein levels | Muscle / cardiac | 1 | 3 | 9 | 20 | |
| 4774 | FKBPL levels | PROLV000812 | 0.02 | Protein levels | Vascular | 10 | 1 | 6 | 12 | |
| 4775 | EFEMP1/TGFBR3 ratio | PRORT000988 | 0.02 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 4776 | SOD1 levels | PROLV001916 | 0.02 | Protein levels | Lymphocyte | 1 | 2 | 10 | 33 | |
| 4777 | FOXJ3 levels | PROLV000825 | 0.02 | Protein levels | Stromal / connective | 0 | 5 | 9 | 28 | |
| 4778 | CD276 levels | PROLV000326 | 0.02 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 4779 | Congenital malformation | REPRO000003 | 0.02 | Reproductive | Lymphocyte | 8 | 2 | 5 | 14 | |
| 4780 | Corneal properties | OPHTH000010 | 0.02 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 4781 | Atrophic skin disorder | DERMA000037 | 0.02 | Dermatologic | Lymphocyte | 12 | 2 | 8 | 14 | |
| 4782 | CDKN2D/TACC3 ratio | PRORT000580 | 0.02 | Protein ratios | Hematopoietic progenitor | 1 | 4 | 11 | 29 | |
| 4783 | IL15/IL18BP ratio | PRORT001342 | 0.02 | Protein ratios | Lymphocyte | 14 | 2 | 11 | 22 | |
| 4784 | CKMT1A or CKMT1B levels | PROLV000442 | 0.02 | Protein levels | Gastrointestinal epithelium | 59 | 0 | 10 | 7 | |
| 4785 | OGN levels | PROLV001465 | 0.02 | Protein levels | Epithelial | 12 | 0 | 9 | 4 | |
| 4786 | TP53I3 levels | PROLV002091 | 0.02 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 4787 | EPHA4 levels | PROLV000718 | 0.02 | Protein levels | Granulosa cell | 35 | 1 | 8 | 20 | |
| 4788 | CPA1/PLA2G1B ratio | PRORT000721 | 0.02 | Protein ratios | Pancreatic epithelium | 44 | 0 | 2 | 5 | |
| 4789 | AMBP levels | PROLV000085 | 0.02 | Protein levels | Epithelial | 92 | 1 | 4 | 11 | |
| 4790 | Cardiovascular disease, none | CARDI000034 | 0.02 | Cardiac | Vascular | 201 | 2 | 5 | 9 | |
| 4791 | KLK4 levels | PROLV001156 | 0.02 | Protein levels | Hepatocyte | 34 | 2 | 7 | 11 | |
| 4792 | ATXN2L levels | PROLV000165 | 0.02 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 4793 | Gallbladder polyp | HPBIL000009 | 0.02 | Hepatopancreatobiliary | Salivary epithelium | 5 | 0 | 6 | 4 | |
| 4794 | MTHFSD levels | PROLV001347 | 0.02 | Protein levels | Stromal / connective | 2 | 2 | 4 | 9 | |
| 4795 | Dental caries | DENTA000004 | 0.02 | Dental | Stromal / connective | 2 | 1 | 4 | 7 | |
| 4796 | MYDGF levels | PROLV001358 | 0.02 | Protein levels | Stromal / connective | 5 | 4 | 9 | 17 | |
| 4797 | ST13 levels | PROLV001951 | 0.02 | Protein levels | Lymphocyte | 2 | 5 | 15 | 39 | |
| 4798 | CSNK1G2 levels | PROLV000543 | 0.02 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 9 | |
| 4799 | SPINT2/TNFSF13 ratio | PRORT001811 | 0.02 | Protein ratios | Neural / glial | 17 | 6 | 11 | 43 | |
| 4800 | IL2RB levels | PROLV001070 | 0.02 | Protein levels | Lymphocyte | 0 | 2 | 8 | 33 | |
| 4801 | Fatty acids, undecenoic acid | LIPID000030 | 0.02 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 4802 | CRYBB2 levels | PROLV000533 | 0.02 | Protein levels | B / plasma cell | 4 | 2 | 6 | 14 | |
| 4803 | DCTD levels | PROLV000602 | 0.02 | Protein levels | Stromal / connective | 0 | 4 | 7 | 12 | |
| 4804 | CA13/TIA1 ratio | PRORT000272 | 0.02 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 25 | |
| 4805 | VWC2L levels | PROLV002181 | 0.02 | Protein levels | Neural / glial | 0 | 0 | 3 | 7 | |
| 4806 | TNFRSF4 levels | PROLV002071 | 0.02 | Protein levels | Lymphocyte | 72 | 1 | 8 | 16 | |
| 4807 | SLC51B levels | PROLV001883 | 0.02 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 4808 | Taurine metabolites | METAB000014 | 0.02 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 4809 | DTX3 levels | PROLV000660 | 0.02 | Protein levels | Renal epithelium | 2 | 0 | 3 | 9 | |
| 4810 | NID1/NID2 ratio | PRORT001588 | 0.02 | Protein ratios | Lymphocyte | 3 | 3 | 8 | 25 | |
| 4811 | EPHA2 levels | PROLV000717 | 0.02 | Protein levels | Epithelial | 41 | 0 | 4 | 2 | |
| 4812 | CD46/SELP ratio | PRORT000458 | 0.02 | Protein ratios | Granulosa cell | 2 | 3 | 7 | 16 | |
| 4813 | CDC26 levels | PROLV000366 | 0.02 | Protein levels | Vascular | 2 | 2 | 6 | 23 | |
| 4814 | DHX58 levels | PROLV000617 | 0.02 | Protein levels | Hepatocyte | 1 | 4 | 9 | 28 | |
| 4815 | DRAXIN levels | PROLV000651 | 0.02 | Protein levels | B / plasma cell | 29 | 2 | 7 | 16 | |
| 4816 | ITGB1BP2/STAT5B ratio | PRORT001388 | 0.02 | Protein ratios | Muscle / cardiac | 13 | 2 | 7 | 24 | |
| 4817 | Female genital inflammation | REPRO000008 | 0.02 | Reproductive | Neural / glial | 0 | 2 | 4 | 4 | |
| 4818 | Sulfate | METAB000051 | 0.02 | Metabolites | Hematopoietic progenitor | 0 | 1 | 5 | 6 | |
| 4819 | Venous disease | VASCU000064 | 0.02 | Vascular | Vascular | 101 | 2 | 6 | 15 | |
| 4820 | CNTN3 levels | PROLV000477 | 0.02 | Protein levels | Hepatocyte | 99 | 4 | 9 | 30 | |
| 4821 | Medication, GERD | GASTR000014 | 0.02 | Gastrointestinal | Neural / glial | 1 | 2 | 7 | 12 | |
| 4822 | Lacrimal disorder | OPHTH000020 | 0.02 | Ophthalmic | Neural / glial | 0 | 0 | 2 | 11 | |
| 4823 | CELA2A levels | PROLV000396 | 0.02 | Protein levels | Pancreatic epithelium | 122 | 0 | 5 | 8 | |
| 4824 | COL9A1 levels | PROLV000493 | 0.02 | Protein levels | Stromal / connective | 7 | 6 | 17 | 22 | |
| 4825 | TNFRSF13B/TNFSF13B ratio | PRORT001848 | 0.02 | Protein ratios | B / plasma cell | 5 | 2 | 9 | 14 | |
| 4826 | MAP2K6/MGMT ratio | PRORT001485 | 0.02 | Protein ratios | Epithelial | 0 | 0 | 11 | 12 | |
| 4827 | STXBP1 levels | PROLV001971 | 0.02 | Protein levels | Stromal / connective | 17 | 1 | 4 | 7 | |
| 4828 | Thigh muscle volume | BMORP000020 | 0.02 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 4829 | FOXO3/SH2B3 ratio | PRORT001179 | 0.02 | Protein ratios | Lymphocyte | 0 | 3 | 17 | 21 | |
| 4830 | TWF2 levels | PROLV002121 | 0.01 | Protein levels | Stromal / connective | 19 | 2 | 7 | 16 | |
| 4831 | LYZL2 levels | PROLV001255 | 0.01 | Protein levels | Hepatocyte | 5 | 3 | 10 | 21 | |
| 4832 | Nerve entrapment syndrome | NEURO000028 | 0.01 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 4833 | DNMBP/TBC1D5 ratio | PRORT000932 | 0.01 | Protein ratios | Granulosa cell | 22 | 4 | 6 | 14 | |
| 4834 | Daytime napping | BEHAV000015 | 0.01 | Behavioural | Neural / glial | 81 | 5 | 11 | 25 | |
| 4835 | MANSC1/PODXL2 ratio | PRORT001484 | 0.01 | Protein ratios | Hepatocyte | 3 | 2 | 10 | 22 | |
| 4836 | COX5B/FXN ratio | PRORT000715 | 0.01 | Protein ratios | Melanocyte | 0 | 2 | 3 | 6 | |
| 4837 | Photodermatitis | DERMA000016 | 0.01 | Dermatologic | Lymphocyte | 2 | 2 | 11 | 29 | |
| 4838 | RAPGEF2 levels | PROLV001705 | 0.01 | Protein levels | Stromal / connective | 2 | 2 | 17 | 40 | |
| 4839 | Female genital dysplasia | REPRO000007 | 0.01 | Reproductive | Hepatocyte | 17 | 2 | 8 | 22 | |
| 4840 | Joint replacement | MSKEL000049 | 0.01 | Musculoskeletal | Hepatocyte | 7 | 1 | 5 | 6 | |
| 4841 | Bone and cartilage disorder | MSKEL000006 | 0.01 | Musculoskeletal | Neural / glial | 1 | 0 | 0 | 4 | |
| 4842 | Asparagine | METAB000018 | 0.01 | Metabolites | Hepatocyte | 6 | 2 | 10 | 14 | |
| 4843 | Chalazion | OPHTH000017 | 0.01 | Ophthalmic | Lymphocyte | 12 | 2 | 19 | 45 | |
| 4844 | LTBR/TNFRSF14 ratio | PRORT001467 | 0.01 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 4845 | Loud music exposure | MISCL000006 | 0.01 | Miscellaneous | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 4846 | UMOD levels | PROLV002140 | 0.01 | Protein levels | Renal epithelium | 66 | 1 | 4 | 7 | |
| 4847 | CCL15 levels | PROLV000281 | 0.01 | Protein levels | Hepatocyte | 36 | 1 | 9 | 18 | |
| 4848 | PARK7/TNFRSF9 ratio | PRORT001621 | 0.01 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 4849 | IGBP1 levels | PROLV001023 | 0.01 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 4850 | Chondrocalcinosis | MSKEL000014 | 0.01 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 4851 | PODXL levels | PROLV001595 | 0.01 | Protein levels | Vascular | 18 | 1 | 5 | 12 | |
| 4852 | GTPBP2 levels | PROLV000944 | 0.01 | Protein levels | Lymphocyte | 6 | 4 | 9 | 17 | |
| 4853 | AMY1A or AMY1B or AMY1C levels | PROLV000089 | 0.01 | Protein levels | Pancreatic epithelium | 33 | 0 | 7 | 9 | |
| 4854 | PDLIM7 levels | PROLV001529 | 0.01 | Protein levels | Platelet | 2 | 0 | 3 | 14 | |
| 4855 | Educational attainment, none | SOCIO000001 | 0.01 | Socioeconomic | Neural / glial | 89 | 6 | 14 | 30 | |
| 4856 | COMMD1 levels | PROLV000495 | 0.01 | Protein levels | Muscle / cardiac | 0 | 3 | 6 | 18 | |
| 4857 | HLAE/IL15 ratio | PRORT001287 | 0.01 | Protein ratios | Lymphocyte | 41 | 2 | 13 | 24 | |
| 4858 | IgA nephropathy | NEPHR000007 | 0.01 | Nephrourologic | Hepatocyte | — | 0 | 3 | 8 | |
| 4859 | PPM1F levels | PROLV001611 | 0.01 | Protein levels | Lymphocyte | 9 | 3 | 8 | 21 | |
| 4860 | Lactose intolerance | METBL000003 | 0.01 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 4861 | IGLL1 levels | PROLV001036 | 0.01 | Protein levels | Muscle / cardiac | 0 | 3 | 8 | 20 | |
| 4862 | MYCT1 levels | PROLV001357 | 0.01 | Protein levels | B / plasma cell | 0 | 2 | 6 | 23 | |
| 4863 | LPP levels | PROLV001224 | 0.01 | Protein levels | Vascular | 0 | 0 | 5 | 7 | |
| 4864 | Forced vital capacity, FVC | RESPI000020 | 0.01 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 4865 | GP1BA/SELP ratio | PRORT001227 | 0.01 | Protein ratios | Salivary epithelium | 3 | 2 | 8 | 11 | |
| 4866 | CEACAM19 levels | PROLV000389 | 0.01 | Protein levels | Cutaneous epithelium | 26 | 1 | 9 | 8 | |
| 4867 | SCARF2 levels | PROLV001783 | 0.01 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 4868 | APOA4 levels | PROLV000119 | 0.01 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 4869 | FAM3B/GPA33 ratio | PRORT001113 | 0.01 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 4870 | MAP2K6 levels | PROLV001267 | 0.01 | Protein levels | Muscle / cardiac | 13 | 5 | 13 | 22 | |
| 4871 | ATXN10 levels | PROLV000164 | 0.01 | Protein levels | Vascular | 7 | 3 | 9 | 20 | |
| 4872 | B2M levels | PROLV000169 | 0.01 | Protein levels | Lymphocyte | 54 | 3 | 16 | 24 | |
| 4873 | CELA3A/CPA1 ratio | PRORT000593 | 0.01 | Protein ratios | Granulosa cell | 40 | 2 | 4 | 6 | |
| 4874 | PNLIP levels | PROLV001591 | 0.01 | Protein levels | Pancreatic epithelium | 103 | 0 | 2 | 8 | |
| 4875 | Family history, breast cancer | MALIG000038 | 0.01 | Malignancy | Myeloid | 0 | 1 | 4 | 8 | |
| 4876 | NFX1 levels | PROLV001401 | 0.01 | Protein levels | Stromal / connective | 0 | 2 | 7 | 17 | |
| 4877 | PPIE levels | PROLV001607 | 0.01 | Protein levels | Neural / glial | 0 | 1 | 7 | 9 | |
| 4878 | CLIP2 levels | PROLV000459 | 0.01 | Protein levels | Vascular | 19 | 1 | 5 | 9 | |
| 4879 | TEX101 levels | PROLV002010 | 0.01 | Protein levels | Pancreatic epithelium | 0 | 0 | 5 | 7 | |
| 4880 | OTUD6B levels | PROLV001477 | 0.01 | Protein levels | Lymphocyte | 13 | 2 | 6 | 19 | |
| 4881 | CX3CL1/DSG2 ratio | PRORT000807 | 0.01 | Protein ratios | Vascular | 33 | 1 | 6 | 8 | |
| 4882 | FABP6 levels | PROLV000756 | 0.01 | Protein levels | Vascular | 4 | 2 | 7 | 11 | |
| 4883 | EPHB6/LAYN ratio | PRORT001037 | 0.01 | Protein ratios | Muscle / cardiac | 6 | 2 | 3 | 13 | |
| 4884 | VSIG2 levels | PROLV002170 | 0.01 | Protein levels | Renal epithelium | 16 | 0 | 8 | 3 | |
| 4885 | RBKS levels | PROLV001709 | 0.01 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 4886 | Hypothyroidism, autoimmune | IMMUN000015 | 0.01 | Immunologic | Lymphocyte | 218 | 2 | 11 | 15 | |
| 4887 | Drink temperature | DTSUP000003 | 0.01 | Diet and Supplement | Neural / glial | 42 | 3 | 5 | 9 | |
| 4888 | Retinal and choroidal disorder | OPHTH000038 | 0.01 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 4889 | BCL2 levels | PROLV000185 | 0.01 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 4890 | GP1BB levels | PROLV000914 | 9.87e-03 | Protein levels | Lymphocyte | 14 | 3 | 6 | 18 | |
| 4891 | TACC3/TBC1D23 ratio | PRORT001824 | 9.81e-03 | Protein ratios | Lymphocyte | 2 | 2 | 9 | 18 | |
| 4892 | Other ear disorder | AUDIO000004 | 9.76e-03 | Auditory | Epithelial | 6 | 0 | 7 | 9 | |
| 4893 | CCN5/IGFBP6 ratio | PRORT000375 | 9.75e-03 | Protein ratios | Stromal / connective | 6 | 1 | 3 | 18 | |
| 4894 | Tooth agenesis | DENTA000003 | 9.74e-03 | Dental | Epithelial | 0 | 0 | 7 | 14 | |
| 4895 | RELL1 levels | PROLV001721 | 9.70e-03 | Protein levels | Neural / glial | 3 | 2 | 4 | 14 | |
| 4896 | NSFL1C/PSMG3 ratio | PRORT001599 | 9.68e-03 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 4897 | AMBP/ASGR1 ratio | PRORT000084 | 9.63e-03 | Protein ratios | Hepatocyte | 68 | 1 | 6 | 6 | |
| 4898 | RUNX3 levels | PROLV001763 | 9.52e-03 | Protein levels | Hepatocyte | 0 | 2 | 4 | 5 | |
| 4899 | EHBP1 levels | PROLV000689 | 9.50e-03 | Protein levels | Stromal / connective | 18 | 3 | 5 | 18 | |
| 4900 | ERBB2/PTPRF ratio | PRORT001044 | 9.49e-03 | Protein ratios | Hepatocyte | 15 | 1 | 4 | 9 | |
| 4901 | GLOD4/MIF ratio | PRORT001219 | 9.46e-03 | Protein ratios | Hepatocyte | 0 | 2 | 7 | 21 | |
| 4902 | TNC levels | PROLV002052 | 9.40e-03 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 4903 | SMAD1/ZBTB16 ratio | PRORT001791 | 9.38e-03 | Protein ratios | Muscle / cardiac | 9 | 3 | 9 | 25 | |
| 4904 | NECTIN2 levels | PROLV001387 | 9.33e-03 | Protein levels | Vascular | 34 | 0 | 5 | 13 | |
| 4905 | Brugada syndrome | CARDI000020 | 9.26e-03 | Cardiac | Muscle / cardiac | 27 | 4 | 6 | 7 | |
| 4906 | HBB levels | PROLV000955 | 9.25e-03 | Protein levels | Hepatocyte | 847 | 1 | 9 | 7 | |
| 4907 | MICB or MICA levels | PROLV001312 | 9.22e-03 | Protein levels | Lymphocyte | 148 | 2 | 12 | 35 | |
| 4908 | ESAM/TGFB1 ratio | PRORT001067 | 9.18e-03 | Protein ratios | Muscle / cardiac | 20 | 4 | 11 | 17 | |
| 4909 | Pregnancy complication, haemorrhage | REPRO000030 | 9.17e-03 | Reproductive | Stromal / connective | 13 | 2 | 3 | 14 | |
| 4910 | TG levels | PROLV002018 | 9.12e-03 | Protein levels | Gastrointestinal epithelium | 11 | 0 | 9 | 10 | |
| 4911 | FEV1/FVC ratio | RESPI000021 | 9.02e-03 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 4912 | Aortic elasticity | VASCU000049 | 8.96e-03 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 4913 | BRAP levels | PROLV000212 | 8.95e-03 | Protein levels | Vascular | 9 | 2 | 7 | 12 | |
| 4914 | CTRC levels | PROLV000558 | 8.94e-03 | Protein levels | Pancreatic epithelium | 90 | 0 | 1 | 3 | |
| 4915 | Age at onset of walking | NEURO000023 | 8.92e-03 | Neurologic | Neural / glial | 11 | 5 | 12 | 21 | |
| 4916 | Pain, chronic | MSKEL000034 | 8.91e-03 | Musculoskeletal | Neural / glial | 29 | 5 | 9 | 29 | |
| 4917 | SLITRK6 levels | PROLV001890 | 8.74e-03 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 4918 | Coronary artery plaque burden | VASCU000056 | 8.69e-03 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 4919 | EPHB4 levels | PROLV000719 | 8.57e-03 | Protein levels | Hepatocyte | 41 | 1 | 7 | 18 | |
| 4920 | AMY2B levels | PROLV000091 | 8.55e-03 | Protein levels | Hepatocyte | 58 | 1 | 6 | 9 | |
| 4921 | CD160/NCR1 ratio | PRORT000378 | 8.53e-03 | Protein ratios | Lymphocyte | 58 | 2 | 12 | 27 | |
| 4922 | RNF41 levels | PROLV001746 | 8.36e-03 | Protein levels | Stromal / connective | 0 | 1 | 6 | 10 | |
| 4923 | JAM2/TGFBR2 ratio | PRORT001397 | 8.01e-03 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 4924 | LTBR levels | PROLV001244 | 7.83e-03 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 4925 | Pancreas volume | HPBIL000029 | 7.72e-03 | Hepatopancreatobiliary | Pancreatic epithelium | 12 | 0 | 4 | 7 | |
| 4926 | RPN1 levels | PROLV001754 | 7.67e-03 | Protein levels | Hepatocyte | 2 | 3 | 8 | 15 | |
| 4927 | CD93 levels | PROLV000362 | 7.60e-03 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 4928 | Weight change | BMORP000016 | 7.57e-03 | Body morphology | Neural / glial | 0 | 1 | 7 | 21 | |
| 4929 | Intestinal disorder | GASTR000012 | 7.53e-03 | Gastrointestinal | Neural / glial | 8 | 2 | 6 | 13 | |
| 4930 | Bipolar disorder | PSYCH000023 | 7.49e-03 | Psychiatric | Neural / glial | 8 | 5 | 17 | 32 | |
| 4931 | DNAJC9 levels | PROLV000636 | 7.34e-03 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 4932 | GRHPR levels | PROLV000932 | 7.26e-03 | Protein levels | Stromal / connective | 2 | 5 | 18 | 40 | |
| 4933 | NPPB levels | PROLV001424 | 7.19e-03 | Protein levels | Muscle / cardiac | 22 | 3 | 8 | 18 | |
| 4934 | IL13RA1 levels | PROLV001047 | 6.95e-03 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 4935 | GRAP2/MAP4K5 ratio | PRORT001241 | 6.90e-03 | Protein ratios | Lymphocyte | 10 | 2 | 13 | 30 | |
| 4936 | AMOT levels | PROLV000087 | 6.86e-03 | Protein levels | Hepatocyte | 22 | 1 | 5 | 15 | |
| 4937 | Hypertension, secondary | VASCU000026 | 6.84e-03 | Vascular | Renal epithelium | — | 0 | 17 | 26 | |
| 4938 | PPL levels | PROLV001609 | 6.81e-03 | Protein levels | Lymphocyte | 0 | 0 | 2 | 6 | |
| 4939 | Consultant specialty, general medicine | MISCL000016 | 6.76e-03 | Miscellaneous | Neural / glial | 2 | 2 | 4 | 6 | |
| 4940 | FAM3B/GUCA2A ratio | PRORT001114 | 6.76e-03 | Protein ratios | Gastrointestinal epithelium | 41 | 0 | 5 | 6 | |
| 4941 | FOLR1 levels | PROLV000822 | 6.69e-03 | Protein levels | Renal epithelium | 21 | 0 | 6 | 4 | |
| 4942 | Biliary atresia | HPBIL000002 | 6.67e-03 | Hepatopancreatobiliary | Stromal / connective | 0 | 2 | 8 | 6 | |
| 4943 | CEACAM16 levels | PROLV000388 | 6.64e-03 | Protein levels | Hepatocyte | 128 | 1 | 7 | 11 | |
| 4944 | Commuting transport | SOCIO000004 | 6.62e-03 | Socioeconomic | Neural / glial | 6 | 4 | 8 | 15 | |
| 4945 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 6.56e-03 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 4946 | PIK3AP1 levels | PROLV001557 | 6.55e-03 | Protein levels | Hematopoietic progenitor | 18 | 3 | 9 | 27 | |
| 4947 | IL15RA levels | PROLV001049 | 6.40e-03 | Protein levels | Lymphocyte | 1 | 0 | 7 | 10 | |
| 4948 | ST6GALNAC2 levels | PROLV001954 | 6.23e-03 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 4949 | Alcoholic liver disease | HPBIL000033 | 6.22e-03 | Hepatopancreatobiliary | Neural / glial | 1 | 3 | 14 | 15 | |
| 4950 | AKT2 levels | PROLV000075 | 6.21e-03 | Protein levels | Stromal / connective | 6 | 3 | 10 | 21 | |
| 4951 | EBAG9/MITD1 ratio | PRORT000960 | 6.21e-03 | Protein ratios | Muscle / cardiac | 0 | 2 | 7 | 18 | |
| 4952 | Arm impedance | BCOMP000013 | 6.14e-03 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 4953 | Potassium | METAB000049 | 6.14e-03 | Metabolites | Muscle / cardiac | 178 | 0 | 4 | 5 | |
| 4954 | Oral health conditions, none | DENTA000009 | 6.05e-03 | Dental | Lymphocyte | 19 | 2 | 15 | 31 | |
| 4955 | MME levels | PROLV001320 | 6.05e-03 | Protein levels | Hepatocyte | 134 | 1 | 5 | 9 | |
| 4956 | BSG/PCDH1 ratio | PRORT000250 | 6.03e-03 | Protein ratios | Neural / glial | 9 | 0 | 5 | 9 | |
| 4957 | EHMT2 levels | PROLV000691 | 5.92e-03 | Protein levels | Granulosa cell | 1 | 3 | 10 | 14 | |
| 4958 | AK1 levels | PROLV000070 | 5.86e-03 | Protein levels | B / plasma cell | 0 | 3 | 15 | 48 | |
| 4959 | CLMP levels | PROLV000461 | 5.79e-03 | Protein levels | Adipose | 9 | 2 | 6 | 5 | |
| 4960 | ESAM/FUT8 ratio | PRORT001061 | 5.75e-03 | Protein ratios | Lymphocyte | 3 | 2 | 13 | 24 | |
| 4961 | GSTA4 levels | PROLV000941 | 5.72e-03 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 4962 | SSNA1 levels | PROLV001950 | 5.70e-03 | Protein levels | Platelet | 5 | 7 | 14 | 25 | |
| 4963 | Cerebral amyloid angiopathy | NEURO000003 | 5.62e-03 | Neurologic | Vascular | 2 | 0 | 6 | 7 | |
| 4964 | DARS1 levels | PROLV000595 | 5.60e-03 | Protein levels | Vascular | 1 | 4 | 6 | 19 | |
| 4965 | Syncope | NEURO000025 | 5.57e-03 | Neurologic | B / plasma cell | 0 | 1 | 6 | 10 | |
| 4966 | Viral hepatitis | IMMUN000076 | 5.51e-03 | Immunologic | Neural / glial | 3 | 4 | 10 | 17 | |
| 4967 | PDLIM5 levels | PROLV001528 | 5.48e-03 | Protein levels | Stromal / connective | 1 | 3 | 13 | 30 | |
| 4968 | Medication, renin-angiotensin system agent | VASCU000040 | 5.43e-03 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 4969 | ADM/CLMP ratio | PRORT000045 | 5.41e-03 | Protein ratios | B / plasma cell | 16 | 2 | 6 | 8 | |
| 4970 | CEACAM20 levels | PROLV000390 | 5.31e-03 | Protein levels | Hepatocyte | 7 | 1 | 8 | 12 | |
| 4971 | Hip circumference, adjusted for BMI | BMORP000005 | 5.28e-03 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 4972 | Obstetric trauma | REPRO000039 | 5.21e-03 | Reproductive | Lymphocyte | 0 | 1 | 12 | 16 | |
| 4973 | CSF volume | NIMAG000018 | 5.15e-03 | Neuroimaging | Stromal / connective | 16 | 2 | 2 | 6 | |
| 4974 | GPIHBP1 levels | PROLV000924 | 5.13e-03 | Protein levels | Granulosa cell | 39 | 1 | 6 | 8 | |
| 4975 | UBAC1 levels | PROLV002132 | 5.10e-03 | Protein levels | Muscle / cardiac | 4 | 2 | 6 | 11 | |
| 4976 | CLIC5 levels | PROLV000458 | 5.08e-03 | Protein levels | Lymphocyte | 0 | 1 | 7 | 23 | |
| 4977 | EPO/TFRC ratio | PRORT001040 | 4.95e-03 | Protein ratios | Lymphocyte | 0 | 4 | 7 | 15 | |
| 4978 | Oedema | MISCL000012 | 4.94e-03 | Miscellaneous | Lymphocyte | 13 | 2 | 8 | 38 | |
| 4979 | Pregnancy complication, obstructed labour | REPRO000031 | 4.88e-03 | Reproductive | Stromal / connective | 0 | 3 | 6 | 11 | |
| 4980 | Panic attack | PSYCH000031 | 4.79e-03 | Psychiatric | Muscle / cardiac | 0 | 1 | 7 | 4 | |
| 4981 | PRSS2 levels | PROLV001644 | 4.51e-03 | Protein levels | Pancreatic epithelium | 76 | 0 | 6 | 7 | |
| 4982 | CUZD1 levels | PROLV000571 | 4.42e-03 | Protein levels | Neural / glial | 1 | 3 | 9 | 19 | |
| 4983 | CD59/PI3 ratio | PRORT000482 | 4.34e-03 | Protein ratios | Respiratory epithelium | 6 | 0 | 8 | 14 | |
| 4984 | TMED8 levels | PROLV002045 | 4.29e-03 | Protein levels | Stromal / connective | 8 | 1 | 3 | 8 | |
| 4985 | ALPP/MSLN ratio | PRORT000083 | 4.22e-03 | Protein ratios | Renal epithelium | 35 | 1 | 5 | 10 | |
| 4986 | Abnormal heart sounds | CARDI000051 | 4.09e-03 | Cardiac | Muscle / cardiac | 19 | 4 | 6 | 14 | |
| 4987 | GRAP2/PTPN6 ratio | PRORT001244 | 4.03e-03 | Protein ratios | Hepatocyte | 6 | 2 | 7 | 12 | |
| 4988 | FADD/PTPN6 ratio | PRORT001110 | 3.97e-03 | Protein ratios | Hematopoietic progenitor | 0 | 0 | 1 | 3 | |
| 4989 | Pain, none | MSKEL000041 | 3.91e-03 | Musculoskeletal | Neural / glial | 10 | 7 | 9 | 20 | |
| 4990 | Consultant specialty, anaesthetics | MISCL000015 | 3.81e-03 | Miscellaneous | Neural / glial | 0 | 4 | 7 | 15 | |
| 4991 | IMPA1 levels | PROLV001084 | 3.80e-03 | Protein levels | Stromal / connective | 1 | 2 | 4 | 10 | |
| 4992 | CELA3A levels | PROLV000397 | 3.77e-03 | Protein levels | Pancreatic epithelium | 72 | 0 | 3 | 1 | |
| 4993 | Ocular refraction | OPHTH000033 | 3.75e-03 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 4994 | NOS1 levels | PROLV001414 | 3.73e-03 | Protein levels | Muscle / cardiac | 0 | 3 | 7 | 10 | |
| 4995 | CDK8_CCNC levels | PROLV000381 | 3.72e-03 | Protein levels | Hepatocyte | 0 | 2 | 8 | 12 | |
| 4996 | MNDA levels | PROLV001329 | 3.65e-03 | Protein levels | Muscle / cardiac | 1 | 4 | 10 | 20 | |
| 4997 | DLL1 levels | PROLV000626 | 3.62e-03 | Protein levels | Renal epithelium | 37 | 0 | 6 | 10 | |
| 4998 | LTBR/SIRPB1 ratio | PRORT001466 | 3.57e-03 | Protein ratios | Lymphocyte | 1 | 1 | 3 | 17 | |
| 4999 | SLC4A1 levels | PROLV001882 | 3.55e-03 | Protein levels | Lymphocyte | 0 | 3 | 7 | 28 | |
| 5000 | Osteochondrodysplasia | MSKEL000054 | 3.46e-03 | Musculoskeletal | B / plasma cell | 0 | 2 | 8 | 18 |